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ABSTRACT 
The co-existence of ~1014 commensal bacteria and host cells in the human 
gastrointestinal (GI) tract creates an environment rich in molecules produced by both. The 
close-proximity of different signals and cells in the GI tract is thought to lead to inter-
kingdom (IK) signaling where bacteria and human cells recognize and respond to signals 
produced by each other. One such IK signaling molecule abundant in the GI tract is 
Norepinephrine (NE), which is known to increase the virulence and pathogenesis of GI 
tract pathogen, enterohemorrhagic E. coli (EHEC). It has also been shown that NE is a 
potent chemoattractant for EHEC as well as for non-pathogenic E.coli. While the effects 
of NE on virulence are well studied, its role as a chemoeffector is not fully understood. 
The overall goal of this work is to comprehensively characterize the chemotaxis response 
of E. coli toward NE and to elucidate the underlying mechanisms. A part of this work is 
also aimed at developing a probabilistic model to simulate the bacterial migration towards 
attractants. 
 We showed that attraction of E. coli RP437 towards NE requires prior exposure to 
a lower concentration of NE during cell growth, and that de novo expression of two 
enzymes - TynA and FeaB - is required for E. coli chemotaxis towards NE. We discovered 
that NE is not the actual chemoattractant but the molecule that E. coli RP437 responds to 
is dihydroxymandelic acid (DHMA) generated from NE. We observed that chemotaxis to 
DHMA requires the Tsr chemoreceptor and the minimum concentration required for a 
detectable chemotaxis response was ~5 nM. We also observed that the chemotaxis 
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response to DHMA was significantly reduced at concentrations greater than 50 µM and 
concluded that negative cooperativity between the two serine-binding sites resulted in 
attenuation of chemotaxis response. 
We investigated the molecular mechanism underlying the conversion of NE to DHMA 
in E. coli RP437, and identified that it requires the QseC histidine kinase and its cognate 
response regulator QseB, and to a lesser extent, the response regulator QseF. We also 
determined that the feaR transcription factor is required for tynA and feaB expression. 
This work is significant as it suggest that host-derived signals such as NE can be converted 
by commensal bacteria to a potent chemoattractant, which can then recruit pathogens that 
possess Tsr-like receptors to the site of infection. 
A probabilistic model was also developed to simulate the chemotaxis behavior of 
bacteria in microfluidic devices. The time-dependent distribution of bacteria in the 
chemotaxis chamber was simulated using MATLAB®. We determined that the time 
dependent bacterial migration in the microfluidic device is influenced by bulk motion of 
the fluid and existing concentration gradient of chemoeffector. The probabilistic model 
can be used to reduce the experimental space required to test the response of an unknown 
chemoeffector in the microfluidic device. 
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CHAPTER I 
INTRODUCTION 
I.1 Background 
The human gastrointestinal (GI) tract harbors approximately 1014 bacteria that belong 
to over 1000 distinct bacterial species and exhibit symbiotic relationships with the host 
(1). Gut bacteria help produce essential B vitamins and vitamin K, help metabolize dietary 
carbohydrates, proteins, and polyphenols in the food, combat against colonization by 
pathogenic bacteria (both foodborne and opportunistic), and play an important role in 
maintaining human health (2). The symbiosis between the resident bacteria of the gut and 
the host is disturbed when pathogenic bacteria enter the GI tract, and a disturbed microbial 
equilibrium is one of the factors that contribute to enteric infections. A diverse group of 
pathogens, the most prevalent being Clostridium, Campylobacter, Escherichia coli, and 
various strains of Listeria, Salmonella, Shigella, Vibrio, and Yersinia, contribute to 
foodborne infections. Of these, Salmonella and E. coli account for over 80% of the 
multistate outbreaks that have occurred in the US over the past decade (3). Specifically, 
enterohemorrhagic E. coli O157:H7 (EHEC, also known as Shiga toxin producing E. coli, 
STEC, or verocytotoxin-producing E. coli, VTEC) is the single most frequently occurring 
pathogen in these incidents. EHEC causes severe and bloody diarrhea as well as hemolytic 
uremic syndrome (HUS). The clinical course of an EHEC infection is shown in Fig. 1.1. 
Approximately three days after the ingestion of EHEC, the patient develops diarrhea, 
abdominal pain, and fever. 
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FIG. 1.1. Clinical course of EHEC infections in children. 3 days after the ingestion of 
pathogen patient develops diarrhea, abdominal pain, and fever. In next 2 – 4 days, the 
diarrhea will become bloody in almost 90% of the cases. A week after the onset of diarrhea 
~15% of the patients develop HUS. Adapted from Mellmann et al. (4). 
The diarrhea will become bloody in almost 90% of the cases over the next 2 – 4 days. 
About one week after the onset of diarrhea, ~15% of the patients (children younger than 
10 years of age) develop HUS (4). HUS is characterized by hemolytic anemia (anemia 
caused by destruction of red blood cells),  uremia (acute kidney failure), and 
thrombocytopenia (low platelet count) (5). HUS can cause life-threatening complications 
such as stroke, coma, high blood pressure, and heart problems (6). 
After ingestion, EHEC travels through the digestive system and attaches to the 
mucosal epithelium of the large intestine to induce typical attaching and effacing (A/E) 
lesions which promote colonization (7). A/E lesions are characterized by intimate 
attachment, microvillous effacement, and actin polymerization under the adherent bacteria 
to form pedestal-like structure (8). The genes responsible for the formation of A/E lesions 
on the host epithelial cells are encoded on a 35.6 kb pathogenicity island known as locus 
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of enterocyte effacement (LEE). This locus contains 41 genes that are divided into five 
major operons (LEE1 through LEE5). They encode a type 3 secretion system (T3SS) and 
various regulators, chaperones, and effector proteins. The LEE-encoded regulator (Ler), 
the first gene encoded in LEE1, acts as the master transcription factor of the pathogenicity 
island, regulating the expression of all other LEE genes (9, 10).  
EHEC infections occur through a three-step mechanism: (a) migration of pathogens 
towards the gut epithelium by recognizing the intestinal luminal environment, (b) 
attachment and colonization of pathogens on the epithelial cells, and (c) infection of cells 
by release of toxins (11, 12). The host factors influencing EHEC infection are not 
completely understood. However, recent studies on diarrheagenic E. coli virulence reveal 
that the neuroendocrine environment present in the gastrointestinal (GI) tract modulates 
the extent of infection (13), including upregulation of EHEC virulence factors by the 
neuroendocrine hormone norepinephrine (NE). NE, a neurotransmitter and stress hormone 
associated with the ‘fight or flight’ response, is released during mental or physical stress, 
trauma, and injury (14, 15). In the GI tract, NE is released by the sympathetic nerves 
innervating the gut. NE has shown to stimulate the expression of Shiga-toxins and LEE-
encoded proteins in EHEC O157:H7 (16), and accordingly, NE increases the adhesion of 
EHEC O157:H7 to cecal mucosa, colonic mucosa, and the ileum (13).  
Of the three steps in the model for EHEC infection, the first (i.e., recognition of the 
GI tract environment and migration) may offer the best opportunity for early intervention. 
The major goal of this work was to investigate the role of NE in modulating the migration 
of bacteria to sites of colonization on the epithelial layer of the GI tract.  
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I.2 Motivation 
Foodborne illness affects approximately 1 in 10 people worldwide and annually results 
in 420,000 deaths (17). According to the Center for Disease Control and Prevention, ~48 
million people in the United States get sick by consuming contaminated food every year, 
resulting in 128,000 hospitalizations and 3000 deaths (18). EHEC alone causes 
approximately 73,000 infections, with 2000 hospitalizations and 60 deaths per year (19). 
Symptoms of an EHEC infection range from abdominal cramps, diarrhea (sometimes 
bloody), and nausea, and can lead to infection of the systemic circulation and death. The 
cost associated with the EHEC infections is very high; it is estimated that the total cost 
associated with EHEC infections just in the United States is ~2 billion dollars /yr (20), 
when hospitalization charges, physician services, drugs, insurance coverage, etc. are taken 
into account. Another important consequence of EHEC infections is the decrease in 
quality of life, and in extreme cases, permanent disability or even mortality. Because the 
infectious dose required for EHEC infections is extremely small (10-100 CFU/mL) (21), 
even a few cells entering the GI tract can lead to infection. 
Unlike infection by other GI tract pathogens like Salmonella, EHEC infections are 
typically not treated with antibiotics, because the genes encoding for the stx (Shiga toxin) 
genes are harbored in a prophage and use of antibiotics such as ciprofloxacin triggers the 
SOS response in EHEC (4). This, in turn, results in the induction of the phage lytic cycle 
and leads to excision of the prophage from the chromosome and co-transcription of stx 
and phage genes. As a result, the levels of Stx in the environment increases significantly. 
Although EHEC does not invade the host cells, Stx can enter the circulation and bind to 
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the Gb3 receptor in renal microvascular endothelial cells, resulting in inhibition of protein 
synthesis, cellular damage, and eventually HUS (22). HUS is particularly dangerous in 
children and elderly people with weakened immune systems. Given the seriousness of 
EHEC infections, understanding the mechanisms underlying EHEC infection can lead to 
the development of approaches for combating human GI tract infections.  
 
I.3 Research importance, objectives, and novelty 
Colonization of the GI tract by EHEC is not random and does not occur at all locations 
and sites (e.g., there is no significant colonization in the small intestine). In human 
subjects, EHEC has been shown to preferentially colonize gut-associated lymphoid tissues 
(GALTs) in the large intestine (23). Therefore, it is reasonable to speculate that the colon 
microenvironment plays a significant role in the events (i.e., initial migration of EHEC 
towards intestinal epithelial cells) that lead to colonization of EHEC. It is likely that the 
multitude of microbial and host signaling molecules in the colon microenvironment play 
an important role in promoting EHEC colonization in the GALTs.  
One such molecule that is abundant in the GI tract (24, 25) and has been previously 
shown to promote the expression of virulence genes and Shiga toxin production in EHEC 
is the neuroendocrine hormone and neurotransmitter NE (26). A majority of prior studies 
have focused on investigating the effect of NE on EHEC virulence gene expression and 
pathogenesis at the epithelial surface (i.e, after EHEC colonization) (13, 16, 26). In 
contrast, this work focuses on events that occur prior to colonization of the GI tract; 
specifically, on the role of NE in EHEC migration towards the epithelial surface. Our 
6 
overall hypothesis is that EHEC senses NE as a chemoattractant and uses local NE 
gradients to reach preferred colonization sites. This hypothesis is supported by previous 
work from our laboratory showing that NE is a chemoattractant for EHEC as well as for 
non-pathogenic E.coli in vitro (27, 28). However, the mechanisms underlying the 
chemotaxis of E. coli towards NE is not known. Thus, the overall goal of this work is to 
undertake a comprehensive characterization of chemotaxis of E. coli toward NE and to 
elucidate the underlying mechanisms. In addition, we have developed a probabilistic 
model to simulate the bacterial migration towards attractants. 
E. coli chemotaxis towards nutrients such as amino acids has been extensively used as 
a model for studying signal transduction in bacteria (29). However, few studies have 
investigated chemotaxis towards non-energy sources such as NE. Therefore, this work 
extends our knowledge about the full repertoire of chemical signals that serve as 
attractants for E. coli. In addition, this study also supports the role of metabolism in the 
generation of a broad range of chemoeffectors starting from a smaller subset of host 
molecules. This paradigm could be especially important in environments such as the GI 
tract, where the generation of chemoeffectors by metabolism carried out by the diverse 
microbiota will be important for controlling the virulence of enteric pathogens such as 
EHEC, as we have observed for NE and DHMA (30). 
This study used the non-pathogenic and more easily manipulated laboratory strain E. 
coli RP437 as a model for investigating chemotaxis toward GI tract molecules. However, 
because E. coli RP437 and EHEC possess the same five chemoreceptors (Tar, Tsr, Tap, 
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Trg, and Aer) and share a high degree of gene and protein sequence homology (31), the 
results from this work will certainly be applicable to EHEC as well. 
 
The specific objectives were to:  
 Characterize the chemotaxis response of E. coli RP437 towards NE and its 
metabolites 
 Investigate the mechanisms underlying the conversion of NE to other metabolites 
in E. coli. 
 Model the chemotaxis behavior of bacteria in microfluidic devices using a 
probabilistic approach 
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CHAPTER II 
LITERATURE REVIEW 
 
II.1 Human microbiota 
  The human microbiota is an aggregate of trillions of microorganisms that reside in 
and on the human body. The number of single-celled microorganisms in the human 
microbiota is estimated to be 10 times greater than the number of cells of the human host 
(1). In addition to the bacteria, the human microbiota includes archaea, fungi, and viruses 
(32). Microorganisms colonize all different parts of the human body (Fig. 2.1), including 
the skin, nose, ear, mouth, lung, GI tract, kidney, and urogenital tract. They make up 1 – 
3 % of the human body mass (33).  
Although the composition of the microbiota depends on anatomical location, 
interpersonal variation is also substantial (34). For example, twins share less than 50 % of 
their bacterial taxa at species level (35). Despite this diversity, the human microbiota has 
conserved core functions, such as maintenance of basic biological processes, provision of 
resistance against colonization by pathogens, and regulation of the immune system. The 
microhabitats of different organs and body parts each have their own specialized 
properties. For example, the gut microbiota help to digest complex carbohydrates, 
participate in lipid metabolism, and produce essential vitamins (32). Microbiota present 
on the skin inhibit surface pathogens by secreting toxic metabolites (36).  
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FIG. 2.1. Colonization of different parts of the human body by microorganisms. The 
figure indicates the taxonomy of the microbiome at the phylum level for different 
anatomical sites. Reprinted by permission from Macmillan Publishers Ltd: Nature 
Reviews Genetics (37), copyright 2012. 
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II.1.1 Human gut microbiota 
The human GI tract, commonly referred to as the gut, spans from the mouth to the 
anus and comprises a connected system of organs that takes in food, extract nutrients and 
energy, and secretes waste material. The GI tract can be divided into upper and lower 
parts. The upper GI tract consists of the mouth, pharynx, esophagus, and stomach, whereas 
the lower GI tract comprises the small intestine, large intestine, and rectum (38). Besides 
its major functions in ingestion, digestion, absorption, and excretion, the human gut is also 
a major component of the immune system. With an estimated surface area of 32 m2 (39), 
the gut and its associated immune components provide protection against entry of 
exogenous pathogens into the blood and lymph circulatory systems (40) as well 
maintaining a healthy and nutrient rich environment for the resident microbiota. The 
human gut microbiota contains ~1014 organisms belonging to more than 1000 species (1).  
Microorganisms display a great deal of heterogeneity with respect to their density and 
composition in different parts of the GI tract. The stomach and the upper part of the small 
intestine (duodenum, jejunum) contains a relatively low number of bacteria (103 to 104 
cells/g) due to the low pH (41). The major microbial types present in the stomach and 
upper part of small intestine are acid resistant lactobacilli and streptococci (41). In 
addition, Helicobacter pylori is present in the stomach of a large percentage of people 
(42). The number of resident bacteria increase to 108 cells/g in the distal small intestine 
(the ileum) and mainly contains certain Clostridium spp. and certain members of the 
phylum Proteobacteria (43). The colon is the primary site of microbial colonization in 
humans with 1012 to 1014 cells/g, and 99.9 % of them are obligate anaerobes. The most 
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abundant bacteria are the member of the genus Bacteriodes, Peptostreptococcus, 
Eubacterium, Clostridium, Fusobacterium, and Bacillus (41, 44). 
In spite of the fact that our GI tract is germ-free upon birth, it is quickly colonized by 
microorganism from the environment and mother’s birth canal (42). The microbiota is 
dynamic and rapidly evolves into a complex microbial ecosystem. Studies have shown 
that the microbial community of 3-year old infant already resembles that of an adult (42, 
45). Although the composition of gut microflora depends on several factors, such as diet, 
age, medications, illness, stress, and lifestyle (46), it has recently been found that over 
90% of the bacterial component of gut microbiota can be represented by four major 
microbial phyla: Bacteroides, Firmicutes, Proteobacteria and Actinobacteria (47). 
The gut microbiota maintains a symbiotic relationship that confers benefits to both the 
members of the microbial community and the host. The host benefits from the microbiota 
because of its metabolic, immunological and protective functions (48, 49). Production of 
short chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, from dietary 
fibers and complex carbohydrates by the colonic bacteria is one example of metabolic 
function of gut microbiota (50). The SCFAs plays an important role in the control of 
epithelial cell proliferation and differentiation in the colon (44). The gut microbiota also 
plays an important role in the synthesis of essential vitamins such as vitamin K, vitamin 
B12, folate, and biotin, which are not produced by the host. Gnotobiotic studies on 
colonization of germ-free mice with specific microorganisms have revealed the important 
role of the microbiota on the development and maturation of the immune system (51). For 
example, studies with germ-free animals show extensive defects in the organization and 
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function of gut-associated lymphoid tissue (GALT) along with reduced antibody 
production, fewer Peyer’s patches, and  impaired development and maturation of isolated 
lymphoid follicles (ILFs)  (46, 51). However, some of these defects can be reversed by 
colonizing germ-free animals with the commensal bacteria (52). The gut microbiota also 
provides resistance to colonization by enteric pathogens through the production of 
antimicrobial substances (such as bacteriocins) and by competing for nutrients required 
by pathogens to establish themselves in the GI tract (53) .  
Several studies have also shown that alterations in the conmposition of the microbiota 
(dysbiosis) is correlated wtih numerous diseases such as metabolic syndrome, cancer, 
inflammatory bowel disease (IBD), Crohn’s disease, and ulcerative colitis (54-58). The 
Human Microbiome Project (HMP), a National Institutes of Health (NIH) initiative started 
in 2008, focuses mainly on understanding the correlation between changes in the 
microbiome and the disease state using metagenomics and genomic DNA-sequencing 
techniques (57).  
 
II.2 Important signaling molecules in the GI tract 
 The gut microbiota produce several metabolites that serve as microbe-microbe and 
host-microbe signaling agents. For example, indole functions as an interspecies and 
interkingdom signaling molecule (59), and autoinducer-2 (AI-2) works primarily as 
quorum sensing (QS) molecule (60). In addition to metabolites produced by gut 
microbiota, the GI tract contains numerous host-derived signaling molecules, such as 
catecholamines (dopamine, epinephrine, norepinephrine, etc.). Epinephrine and 
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norepinephrine, in particular, have been shown to affect microbial populations in the GI 
tract and can also influence virulence factors production in the invading pathogens (26, 
61-63). 
 
II.2.1 Norepinephrine (NE) 
NE is a catecholamine neurotransmitter of the sympathetic nervous system that 
enervates the GI tract (64). NE is synthesized from tyrosine by a series of enzymatic steps 
in the adrenal medulla and by postganglionic neurons of the sympathetic nerve system 
(65). The first step in the synthesis of NE involves conversion of tyrosine to L-DOPA and 
is catalyzed by the enzyme tyrosine hydroxylase (TH). DOPA is converted into dopamine 
by the enzyme DOPA decarboxylase. Finally, dopamine is converted into NE by the 
enzyme dopamine β-hydroxylase (DBH) and released into the gut lumen from the 
noradrenergic nerve endings in the GI tract. When there is excess NE production (e.g., 
after a major injury, infection, or stress), NE spills over into the GI tract lumen, where it 
affects the composition of the microbial community (66-69). Previous studies have shown 
that NE stimulates the growth of various Gram-negative and Gram-positive bacteria, 
including Pseudomonas aeruginosa, Yersinia enterolitica, Salmonella enterica, and 
Listeria spp (67). It was found that NE increased adhesion of EHEC O157:H7 to cecal 
mucosa, colonic mucosa, and the ileum (13). NE also increases the secretion of virulence 
determinants like elastase, rhamnolipid, and pyocyanin in P. aeruginosa PA14 (70), 
enhances growth, motility, and invasiveness in Campylobacter jejuni (61), and up-
regulates expression of virulence factors in S. enterica Typhimurium (71).  
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We have found that NE is a chemoattractant for EHEC as well as for non-pathogenic 
E.coli in vitro (27, 28). Experiments with a series mutants of E. coli RP437 have revealed 
that attractant response to NE is primarily mediated by serine chemoreceptor, Tsr, and that 
pre-exposure to NE results in de novo expression of proteins required for NE chemotaxis 
(28). Wild-type E.coli RP437 cells were attracted toward an agarose plug containing 200 
µM NE (28), whereas B. pilosicoli are attracted to NE even when the NE concentration in 
a capillary assay (see below) is as low as 0.05 mM (72). 
In humans, NE is rapidly degraded to various metabolites. Either monoamine oxidase 
A (MAO-A) or catechol – O –methyl transferase (COMT) catalyzes the initial step in the 
NE metabolism (73). MAO-A deaminates NE to 3, 4-dihydroxyphenyl-glycolaldehyde 
(DOPEGAL) (73). This potentially toxic aldehyde intermediate metabolite rapidly 
undergoes further metabolism to form either stable alcohol or acid metabolites (73). 
Aldehyde dehydrogenase converts DOPEGAL to 3,4-dihydroxy-mandelic acid (DHMA) 
and aldehyde reductase converts DOPEGAL to 3,4-dihydroxy-phenylglycol (DHPG) 
(73). Finally, vanillylmandelic acid (VMA), the major end product of NE metabolism, is 
formed by the action of COMT on DHMA (73). 
II.3 Escherichia coli chemotaxis
Chemotaxis is the directed migration of organisms toward or away from higher 
concentrations of chemicals that are sensed as attractants or repellents, respectively (74). 
Chemotaxis of E. coli toward metabolizable compounds has been well studied (75-77). 
E. coli migrate toward amino acids (e.g., aspartic acid, serine), sugars (maltose, ribose, 
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galactose, glucose), dipeptides, pyrimidines and electron acceptors (oxygen, nitrate, 
fumarate) (78-80). They move away from a broad range of compounds including alcohols, 
fatty acids, glycerol, and metal ions (e.g., Ni2+) (81-83).  
 When present in an isotropic chemical environment E. coli have two modes of movement 
(80). They swim smoothly in relatively straight line, called a “run”, and then abruptly 
change direction in a chaotic movement known as a “tumble” (80). Because of the 
alternating run and tumble modes, the migration of a bacterial cell has been described as 
a random walk (80). When cells encounter an increasing concentration of an attractant, 
the tumble frequency is reduced and longer runs are attained, which results in a biased 
random walk (Fig.2.2). As a result, cells migrate toward higher concentrations of an 
attractant (80). Conversely, bacteria tumble more frequently if they encounter an 
increasing concentration of repellent (80). In E.coli, the run and tumble modes of 
movement are correlated with the direction of rotation of the flagellar motor. 
Counterclockwise (CCW) rotation promotes formation of a left-handed helical flagellar 
bundle that produces a force on the cell body that causes the cell to swim smoothly (84). 
In contrast, clockwise (CW) rotation of one or more flagella destabilizes the bundle and 
causes the cell to tumble (84). In a uniform signaling environment, runs last an average of 
~2 s and are interrupted by short tumbles  of ~0.1 s (85). 
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FIG. 2.2. Chemotaxis behavior of E. coli. Through alternate (A) Run, (B) Tumble modes 
of movement, bacteria attains random walk when present in (C) uniform signaling 
environment. When present in (D) attract gradient, the run gets longer and frequency of 
tumbling is reduced which results in biased random walk. 
 
E. coli senses chemoeffector gradients in a temporal fashion by comparing the current 
concentrations to those encountered over the past few seconds of travel (86, 87) . This 
ability implies that E. coli possess a 3–4 s memory that is used to determine whether 
chemoeffector levels have changed. Upon detecting an increase in attractant 
concentration, the cells will continue to swim smoothly in the direction of gradient due to 
suppression of tumbles (Fig.2.2). 
The sensing of different chemoeffectors is carried out by transmembrane 
chemoreceptors. E. coli has five such chemoreceptors: Tsr (taxis to serine and away from 
some repellents), Tar (taxis to aspartate and maltose and away from some repellents), Trg 
(taxis to ribose and galactose/glucose), Tap (taxis to dipeptides and pyrimidines) and Aer 
(aerotaxis) (88). Of these, four (Tsr, Tar, Tap, and Trg) are methyl-accepting 
transmembrane receptors or methyl-accepting chemoreceptor protein (MCP) (88). These 
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receptors have a periplasmic domain with distinct ligand-binding sites and a conserved 
cytoplasmic signaling domain (Fig.2.3).  
A fifth MCP-like protein, Aer, mediates aerotactic responses by monitoring redox 
changes in the electron transport chain (86). Aer undergoes sensory adaptation through a 
poorly understood, methylation-independent mechanism. The five MCP-family receptors 
in E. coli utilize a common set of cytoplasmic signaling proteins to control flagellar 
rotation and sensory adaptation (Fig. 2.3) (86). There are six cytoplasmic signaling  
proteins: CheA, CheB, CheR, CheW, CheY, and CheZ. When present in a chemoeffector 
gradient, membrane-bound receptors change their conformation upon binding a ligand. 
This conformational change results in autophosphorylation of the cytoplasmic histidine 
kinase CheA, which forms a stable complex with the receptor along with an adaptor 
protein CheW. CheA then donates its phosphoryl group to two competing response 
regulators, CheB and CheY. CheY-P binds to flagella motor and induces CW rotation. 
Binding of attractant to a chemoreceptor inhibits the CheA activity and leads to a lower 
CheY-P concentration, which promotes smooth swimming. The rapid dephosphorylation 
of CheY-P is ensured by the phosphatase CheZ. The MCPs record the most recently 
encountered ligand concentration by reversibly methylating four or five specific glutamic 
acid residues in the cytoplasmic signaling domain of each monomer of the chemoreceptors 
(86). The methyltransferase, CheR, and the methylesterase, CheB, mediate the 
methylation and demethylation of the receptors, respectively. Increased receptor 
modification increases the activity of the associated CheA, and, as a result, cells adapt to 
a homogeneous chemical environment (89).  
18 
FIG. 2.3. E. coli chemotaxis signaling network components. Five E. coli chemoreceptors 
Tsr, Tar, Tap, Trg, and Aer are shown along with their chemoeffector ligands serine, 
maltose/ aspartate, dipeptides/pyrimidines, galactose/ribose, and oxygen respectively. All 
five receptors employ a common set of cytoplasmic signaling proteins, CheW and CheA, 
which interact with cytoplasmic domain of chemoreceptor to form stable ternary 
complexes that generate stimulus signals in the form of phosphoryl groups. CheY and 
phospho-CheY signal the CCW and CW flagellar rotation, CheZ controls the 
phosphorylation or dephosphorylation of cheY, CheR (methyltransferase) and CheB 
(methylesterase) regulate the MCP methylation state. 
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II.4 Methods for studying bacterial chemotaxis 
 
II.4.1 Swim and swarm plate assays 
Plate assays are generally used to study the chemotaxis behavior of bacteria toward a 
chemoeffector that can be metabolized (90). For swim plate assays, motility medium 
containing agar concentrations of 0.25 to 0.4% are used (90). At this low concentration of 
agar, the bacteria can move through the long aqueous channels formed inside the agar. As 
the colony grows, its metabolism depletes attractants to create a spatial concentration 
gradient in the agar. As a result, the cells migrate outward toward higher concentrations 
of the attractant compound (90). The strength of attraction can be assessed by measuring 
the rate of formation of the chemotactic ring that is formed by cells in the region of the 
steepest gradient (90). A variation of the swim plate assay is the swarm assay. In this 
assay, motility medium containing higher concentrations of agar (0.5% to 0.7%) are used, 
and the cells swim through the aqueous layer that forms on the agar surface (91). 
Swarming cells typically produce more, and longer, flagella (91). Neither swimming or 
swarming assays are useful for measuring repellent taxis or chemotaxis toward 
chemoeffectors that cannot be metabolized by the bacteria (90). 
 
II.4.2 Capillary assay 
The capillary assay is commonly used for investigating bacterial chemotaxis. Adler et 
al. (79) developed the assay and used it to demonstrate the chemotaxis response of E. coli 
towards a wide range of attractants and repellents. In this assay, chambers on the order of 
20 
1 cm2 made from plastic O-rings with a 60o cut and 1 mm in height are loaded with a 
suspension of highly motile bacteria in chemotaxis buffer to create a pond under a 
coverslip (Fig. 2.4). A capillary (1 µL column) is sealed by flaming one end and placed 
with its open end into a solution of an attractant at the desired concentration, which is 
drawn up into the capillary as it cools. The filled capillary is inserted into the pond and 
incubated at the desired temperature for 30 to 45 minutes. The chemoeffector in the 
capillary will diffuse out into the pond to create a gradient that the can be sensed by the 
bacteria. The bacteria will then migrate into the capillary if the chemoeffector is an 
attractant and is not present at too high a concentration (above saturation of the receptor 
being tested). The capillary is then removed, the sealed end carefully broken off, and the 
contents delivered into dilution buffer. Dilutions are plated on nutrient agar, and colonies 
are counted the next day. The colony counts allow a calculation of the number of cells that 
entered the capillary and used to compare the strength and concentration dependence of 
the chemotaxis response to various compounds. The capillary assay can also be used for 
measuring repellent taxis, but the results are less sensitive as those for attractants. For 
example, Tso et al. (83) modified the capillary assay by placing the chemorepellent acetate 
in the pond of bacteria and filling the capillary with buffer. The number of bacteria that 
‘flee’ into the capillary for ‘refuge’ is used to measure the repellent response. Not 
sruprisingly, the number of bacteria that accumulate in the capillary is not as high as for 
an attractant response, and the threshold concentration for detecting a repellent response 
is also higher (83). 
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FIG. 2.4. Experimental setup for the capillary assay. 
1. Glass slide 
2. Plastic o-rings cut at one end 
3. Ponds containing highly motile cells 
4. Cover slip 
5. Capillary tube containing chemoeffector 
6. Capillary tube with cells along with the chemoeffector 
 
 
II.4.3 Plug-in-pond assay 
 Tso et al. (83) developed the chemical-in-plug assay, a simple and quick way of 
measuring repellent or attractant chemotaxis. In this assay, a hard agarose plug (2%) 
containing chemoeffector is surrounded with a turbid suspension of bacteria in soft agar 
(0.3%). A zone of clearance quickly appears around the hard agar plug if the chemical 
within the plug is a repellent, and cells aggregate around the plug if it contains an 
attractant. The variation on chemical-in-plug assay is agarose-in-plug bridge method 
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developed by Yu et al. (92) later gained popularity as plug-in-pond assay in which molten 
agarose solution (2-4%) containing potential attractant or repellent is placed on a cover 
slide, and a coverslip is placed on top of the agarose to form the plug. The coverslip is 
kept in place using plastic stripes on either side of the plug. About 100 µl of the cell 
suspension is introduced between the microscope slide and the glass coverslip through 
capillary action, and the chemotaxis response in terms of distribution of cells around the 
agarose plug is observed using a microscope. Although this assay is widely used for rapid 
screening of attractants, it is prone to false positive response if appropriate controls are 
not used (93). 
 
II.4.4 Micro-plug (µPlug) assay 
The μPlug assay (90) is an improved version of the well-established plug-in-pond 
assay (91). It consists of a 15 × 15 mm square microfabricated chamber in poly-
dimethylsiloxane (PDMS) with a height of ~75 μm. Low-melting agarose mixed with 
chemoeffector is introduced through a 1.5 mm diameter hole in the middle of the chamber 
to create plug. Two additional holes are punched with a blunt 19-gauge needle along the 
diagonal, one of which to introduce cells into the chamber, and the other to provide a vent 
as shown in Fig. 2.5. The chemoeffectors diffuses out of the plug and forms a radial 
concentration gradient around the plug. The bacteria sense the gradient, and if the 
molecule being tested is an attractant, they will move up the concentration gradient and 
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FIG. 2.5. Experimental setup for µPlug assay. GFP-labeled bacteria suspended in CB are 
introduced at the inlet, and the outlet allows escape of air. The agarose plug contains CB 
plus chemoeffector at the desired concentration. The plug is visualized by addition of 5% 
bromophenol blue to provide optical contrast. The cartoon shows the distribution of GFP-
labeled cells when they are first introduced (t = 0 min) and at the end of the experiment (t 
= 30 min). 
accumulate at the boundary of the plug. If the molecule being tested is a chemorepellent, 
fewer cells accumulate at the plug boundary. With bacteria that express fluorescent 
proteins, the accumulation of cells at the interface can be imaged and the chemotactic 
response determined. Although the μPlug assay provides a simple and rapid method for 
determining the chemotaxis response of cells to a molecule, it does not facilitate 
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quantification of the response. Moreover, this method also suffers from the same 
drawbacks as the capillary assay in that it is not suited to studying repellent responses.  
 
II.4.5 Micro-flow (µFlow) assay 
 The µFlow assay (94) was developed in order to address the above mentioned 
challenges and obtain quantitative information about the chemotactic response of bacteria 
toward chemoeffectors. The μFlow device builds on a simpler flow cell developed by Mao 
et al (95), in which bacteria are introduced between two parallel streams containing buffer 
and a chemoeffector. Bacteria sense the chemoeffector at the interface between the two 
streams and either swim toward the chemoeffector containing stream (for an attractant) or 
away from the interface of the two streams (for repellents).  
The μFlow device (94) integrates a microfluidic concentration-generator (96) and a 
chemotaxis observation chamber for visualizing bacterial migration in response to the 
chemoeffector. The concentration-gradient generator consists of a pyramid-shaped 
branched network of microfluidic channels fabricated in PDMS. The network of 
microchannels enables splitting, combining, and mixing of fluid streams as they flow 
through the network. In a two-inlet μFlow device, the two fluid flow streams containing 
chemoeffector and buffer are brought together and mixed and then split into three 
streams. Since the flow is laminar, mixing between the two streams occurs mainly 
through the process of diffusion among the three fluid streams contain different 
proportions of chemoeffector. This process of mixing and splitting is repeated several 
times to generate a nearly linear concentration gradient across the width of the chemotaxis 
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chamber. Non-linear gradients can also be generated either by increasing the number of 
inlets or changing the flow characteristics. Hegde et al. (97) employed a µFlow device 
to generate an exponential gradient of 0 – 200 µM by using 5 inlets with different 
chemoeffector concentrations (0, 0.2, 2, 20, 200 µM).  
The gradient generated by µFlow device is stable throughout the length of the 
observation chamber. Although bacteria entering the chemotaxis observation chamber in 
the device developed by Mao et al. (95) encounter a sharp interface between the cell buffer 
and the chemoeffector solutions, cells in the µFlow device encounter the midpoint of the 
generated concentration gradient. Depending on the flow rate used, bacteria are exposed 
to the gradient for different times, typically around 20 seconds to traverse the 2 cm length 
of the chamber. The extent of migration in the corss-gradeint direction is captured by 
acquiring 100 green and red fluorescence images for 20 min. The images are analyzed 
using in-house developed Matlab analysis codes to enumerate bacterial counts at different 
locations across the width of the chemotaxis chamber (98).  
In µFlow device the chemotaxis response of bacteria towards the chemoeffector 
gradient is quantified in terms of chemotaxis migration coefficient (CMC), which weights 
the migration of cells by the distance they move from the center of the observation 
chamber (95). For example, a cell that moved to the farthest high-concentration position 
at the right was given a weighting factor of +1, and a cell that moved to the farthest low-
concentration position at the left was given a weighting factor of -1. Therefore, a higher 
CMC value can be interpreted as a stronger chemotaxis response of the bacteria to the 
coeffector.  
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II.5 Mathematical modeling of bacterial chemotaxis
Mathematical modeling of bacterial migration is not only necessary to interpret the 
experimental data but also is used as an essential tool to predict the behavior of bacterial 
populations in response to different environmental conditions (99). Several mathematical 
models have been proposed to describe different aspects of chemotaxis behavior at the 
single-cell level (100-103) and at the population level (104-109). Most of the population 
based models are based on the Keller–Segel model of chemotaxis, which was developed 
to model the movement of slime molds. The generalized Keller–Segel model is of the 
following form: 
Where 𝑢 = 𝑢(𝑥, 𝑡) is the density of bacterial population, 𝑣 = 𝑣(𝑥, 𝑡) is the concentration 
of attractant, 𝜇(𝑣) is the bacterial diffusion coefficient, 𝜒(𝑣) is the chemotactic sensitivity 
coefficient, 𝑔(𝑢, 𝑣) and ℎ(𝑢, 𝑣) are the cell growth and death functions, respectively, 
𝑓(𝑢, 𝑣) is the function describing the degradation of attractant, and 𝐷 is the diffusion 
coefficient of attractant. 
 Although the partial differential equations (PDEs) (1.1) and (1.2) can be solved with 
appropriate boundary condition for given initial bacterial and attractant distribution it is 
always challenging to obtain numerical solutions without several assumptions. Also, this 
model doesn’t account for the active motion of the bacteria and single cell dynamics (110). 
𝜕𝑢
𝜕𝑡
= ∇.𝜇(𝑣)∇𝑢 −  ∇.𝜒(𝑠)𝑢∇𝑣 + 𝑔(𝑢, 𝑣) − ℎ(𝑢, 𝑣) 
𝜕𝑣
𝜕𝑡
= 𝐷𝛻2𝑣 −  𝑓(𝑢, 𝑣) 
        (1.1) 
        (1.2) 
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CHAPTER III 
CHEMOTAXIS OF ESCHERICHIA COLI TO NOREPINEPHRINE (NE) 
REQUIRES CONVERSION OF NE TO 3,4-DIHYDROXYMANDLEIC ACID 
(DHMA)* 
III.1 Overview
Norepinephrine (NE), the primary neurotransmitter of the sympathetic nervous 
system, has been reported to be a chemoattractant for enterohemorhagic E. coli (EHEC). 
Here, we show that non-pathogenic E. coli K-12 grown in the presence of 2 M NE also 
is attracted to NE. Growth with NE induces transcription of genes encoding the tyramine 
oxidase, TynA, and the aromatic aldehyde dehydrogenase, FeaB, whose respective 
activities can, in principle, convert NE to 3,4-dihydroxymandelic acid (DHMA). Our 
results indicate that the apparent attractant response to NE is in fact chemotaxis to DHMA. 
DHMA was found to be a strong attractant for E. coli. Only strains of E. coli K-12 that 
produce TynA and FeaB exhibited an attractant response to NE. We demonstrate that 
DHMA is sensed by the serine chemoreceptor Tsr and that the chemotaxis response 
requires an intact serine-binding site. The threshold concentration for detection is ≤ 5 nM 
DHMA, and the response is inhibited at DHMA concentrations above 50 M. 
*Reprinted in part with permission from “Chemotaxis of Escherichia coli to Norepinephrine
(NE) Requires Conversion of NE to 3,4-Dihydroxymandelic Acid (DHMA)” by Sasi 
Pasupuleti, Nitesh Sule, William B. Cohn, Duncan S. MacKenzie, Arul Jayaraman, 
Michael D. Manson, 2014, Journal of Bacteriology, 196:3992-4000. Copyright by 
American Society for Microbiology 
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Cells producing a heterodimeric Tsr receptor containing only one functional serine-
binding site still respond like wild type to low concentrations of DHMA, but their response 
persists at higher concentrations. We propose that chemotaxis to DHMA generated from 
NE by bacteria that have already colonized the intestinal epithelium may recruit E. coli 
and other enteric bacteria that possess a Tsr-like receptor to preferred sites of infection. 
III.2 Introduction
The human gastrointestinal (GI) tract harbors an assortment of bacteria, most of which 
are harmless or helpful commensals. However, infection of the GI tract by pathogenic 
bacteria can have devastating consequences. It has been suggested that norepinephrine 
(NE), the predominant neurotransmitter of the enteric sympathetic nervous system, 
promotes growth and virulence of enteric bacteria (111) through signaling via adrenergic 
receptors located either on intestinal epithelial cells (112) or in the bacteria themselves 
(113, 114). In particular, the bacterial quorum sensor kinase QseC has been implicated in 
the NE-induced expression of genes whose products are involved in adherence, motility, 
and pathogenesis (113, 115). However, the concentrations of NE required for effective 
induction of virulence genes, 50 M in one recent study (71), are higher than those that 
are expected to occur in the intestinal lumen (69, 116). Thus, for NE to activate expression 
of virulence factors, bacteria would have to navigate to regions of the intestinal epithelium 
that have locally high concentrations of NE. An obvious candidate for directing such 
migration is chemotaxis. 
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Chemotaxis in E. coli is well understood at the molecular level. However, the 
compounds that have been reported as chemoattractants (31) are primarily nutrients: serine 
and related amino acids, sensed by the chemoreceptor Tsr; aspartate and maltose, sensed 
by Tar; ribose and galactose, sensed by Trg; and dipeptides and pyrimidines, sensed by 
Tap. The significance of chemotaxis to these compounds as virulence factors, except in 
the general sense of increasing nutrient acquisition to promote growth, is unclear. Another 
under-appreciated problem with prior studies of the role of chemotaxis in pathogenesis is 
that wild-type cells are compared with totally non-chemotactic, smooth-swimming 
mutants rather than with mutants having normal motility patterns but defects in 
chemotaxis to specific chemoeffectors. Thus, it remains unclear whether it is chemotaxis 
per se that is responsible for the observed effects or whether an altered pattern of run-
tumble motility is responsible for the differences observed. 
NE has been reported as an interdomain signaling molecule (27, 115, 117). NE serves 
as an inducer of virulence and motility genes in enterohemorhagic E. coli (EHEC) and in 
S. enterica (27, 71). The primary signaling pathway for induction of virulence appears to 
go through the membrane-bound quorum-sensing kinase QseC and its associated response 
regulator, QseB (118). The relationship between stress and microbial infection suggests 
that increased catecholamine concentrations in the intestine promote bacterial growth (68) 
and colonization (62). However, the effects of NE in enhancing virulence require higher 
concentrations than those that are predicted to exist in the gut, and in some cases appear 
to be independent of QseC and instead related to the ability of NE to serve as an iron 
chelator (119). However, both  and -adrenergic receptor antagonists inhibit the 
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responses of enteric bacteria to catecholamines, and receptors other than QseC, including 
QseE, BasS, and CpxA, have been reported to contribute to the bacterial response to 
adrenergic signals (115). The current study was undertaken to determine the mechanisms 
underlying chemotaxis to NE in order to assess whether chemotaxis may contribute to the 
virulence of enteric bacteria. 
 
III.3 Materials and methods 
 
III.3.1 Bacterial strains and solutions 
Strain CV1 is equivalent to strain RP437 (120) but was renamed to conform to the 
nomenclature of other strains used in this study. It was used as the wild-type E. coli strain 
for chemotaxis. All relevant strains and plasmids are listed in Table 3.1. Liquid cultures 
were grown in tryptone broth (TB; 10 g/L tryptone and 8 g/L NaCl). Selection for 
kanamycin resistance was on Luria-Bertani agar containing 1.2 % Difco Bactoagar and 50 
g/ml kanamycin. TB semi-solid agar contained 0.35 % Difco Bactoagar. H1 minimal-
glycerol TLHMB1 agar contained 1.2 % Difco Bactoagar and was supplemented with 0.5 
% glycerol, 20 g/mL threonine, leucine, histidine, and methionine, and 1 g/mL 
thiamine. Chemotaxis buffer (CB) contains physiological buffered saline with 10 mM 
potassium phosphate, pH 7.0, containing 0.1 mM EDTA, 0.01 mM L-methionine, and 10 
mM DL-lactate. Expression of Tsr from plasmids pCA24N-tsr and pRR53-tsrR69E was 
induced with 100 M isopropylthiogalactoside (IPTG). This concentration of inducer gave 
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optimal serine chemotaxis in tryptone semi-solid agar when wild-type Tsr was expressed 
from pCA24N-tsr in tsr strain CV5. 
III.3.2 Reagents
Norepinephrine (NE) and 3,4-dihydroxymandelic acid (DHMA) of reagent grade and 
were obtained from Sigma-Aldrich. 
III.3.3 Generation of mutants
The tynA, feaB, and qseC kan-insertion knockout mutations in strains SP101-103 were 
introduced into strain CV1 by phage P1vir transduction from the respective mutants in the 
Keio collection (121), with selection for resistance to 50 g/mL kanamycin. The insertions 
were confirmed by Southern blotting. Chromosomal tsr point mutations were introduced 
into strain CV1 in two steps. First, a serB-kan insertion from strain UU2641 was 
introduced into strain CV1 by P1vir transduction with selection for resistance to 50 g/mL 
kanamycin on Luria Broth (LB) agar to generate strain TAMU100. The tsr mutations were 
then introduced into strain TAMU100 by P1vir transduction with lysates prepared on 
strains UU2375 and UU2376, which contain chromosomal tsr alleles encoding Tsr-R69E 
and Tsr-T156K, respectively, to generate strains TAMU101-102. Selection for Ser+ 
transductants was accomplished by plating on minimal-glycerol TLHMB1 agar, and the 
presence of the tsr mutations was screened by testing transductants on TB semi-solid agar 
and picking isolates that did not form the outer (serine) chemotaxis rings. Glycerol was 
used as the carbon source in minimal medium because glucose adventitiously induces 
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transcription of the ccdB (control of cell death) gene from the rhaB promoter in the kan-
insertion that allows counter-selection for loss of the insertion in the presence of rhamnose 
(122). CcdB is potent gyrase inhibitor (123) that is the toxin of an addiction system of the 
F plasmid of E. coli (124). 
III.3.4 Fabrication of the microflow device
Microflow devices were fabricated as previously described (90). Briefly, device 
designs were drawn in AutoCAD and used to create a high-resolution (>3000 dpi) 
photolithography mask with a laser printer (Advanced Reproductions, North Andover, 
MA). Standard photolithography techniques using an SU-8 2050 photoresist (Microchem 
Corp, MA) generated imprints of the microflow devices on silicon wafers. The silicon-
wafer templates were used as negative molds to generate the chemotaxis devices in 
poly(dimethyl)siloxane (PDMS), using standard soft-lithography protocols (90). Chamber 
dimensions were measured using a profilometer. Devices were fabricated by bonding the 
patterned PDMS slab to clean glass slides, using oxygen-plasma bonding in a plasma 
etcher (100 mTorr, 100 W, 40 sec) to create optically transparent devices. Access ports 
were punched into the PDMS using a blunt 19-gauge needle. 
III.3.5 Microflow assay
The microflow assay for chemotaxis (90) measures the chemotactic response of 
bacteria, fluorescently labeled by GFP expression. When the cells enter the observation 
chamber they encounter a stable concentration gradient of chemoeffector established 
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across the width of the microfluidic chamber. The microflow chemotaxis device consists 
of two modules – a concentration-gradient generator and a chemotaxis-observation 
chamber. The gradient generator comprises a network of microfluidic channels that uses 
diffusive mixing from five inputs to generate non-linear, approximately exponential 
concentration gradients across the width of the observation chamber. The length of the 
network is 18.5 mm. The width of each inlet entering the observation chamber is 500 µm. 
The observation module is a chamber (20 µm x 1050 µm x 2 cm µm) connected to the 
gradient-generator module. A secondary inlet (50 µm) is used to introduce bacteria into 
the observation module at the mid-point of the concentration gradient. The bacteria and 
the concentration gradients are introduced into the device through silicon tubing. The 
device infused with dyes of different colors is shown in Fig. 3.1. 
The assay was performed as described previously (90). A mixture of GFP-
expressing, motile test cells and RFP-containing, dead TG1 cells was gently resuspended 
in CB containing the chemoeffector at the concentration expected at the mid-point of the 
observation chamber and incubated for 20 min. All steps were conducted at room 
temperature. The flow rate in the microfluidic device was controlled using a PicoPlus 
programmable pump (Harvard Apparatus, Holliston, MA). The assembled device was 
positioned on the stage of a Leica TCS SP5 resonant-scanner confocal microscope. 
Multiple 500 µL gas-tight glass syringes (Hamilton, Reno, NV), containing either CB or 
CB with chemoeffector, were carefully connected to the inlets of the gradient-generator 
module to avoid introducing air bubbles into the device. The bacterial mixture was 
introduced into the chemotaxis chamber through the bacterial inlet port, using a 50 µL 
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  gradient
FIG. 3.1. The µFlow assay. In this photograph, a different colored dye is injected by each inlet to illustrate how gradients 
form and persist for the length of the 20 µm high chemotaxis chamber, whose geometry allows laminar flow. With this device 
we would typically inject ten-fold higher chemoeffector concentrations at each inlet from top to bottom, generating a steep, 
exponential gradient. Other inlet configurations allow linear or other shaped gradients to be made. The inset shows the 
distribution of wild-type E. coli cells in a 0 to 50 µM DHMA gradient (inputs of 0, 0.05, 0.5, 5, and 50 µM). 
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gas-tight glass syringe. The syringes connected to the gradient generator and the bacterial 
inlet were operated at the same flow rate, using different pumps. The total flow rate in the 
observation module (from the five gradient inlets and one bacterial inlet) was maintained 
at 2.1 L/min. Green and red fluorescent images were acquired for 20 min. For each 
experiment, 100 images for each fluorophore were collected 7 mm from the inlet at 2.5 
sec intervals. The 2.5 sec imaging interval was chosen based on our calculation that free-
floating bacteria moving at a flow rate of 2.1 L/min take an average of 2.5-3 sec to 
traverse 1000 m, the imaging field-of-view (90). Therefore, bacteria in the middle of the 
flow were exposed to the gradient for an average of 18-21 sec prior to imaging. Cells 
spending more time in contact with the floor or ceiling of the chamber move more slowly 
(94). 
III.3.6 Quantification of chemotaxis in the microflow assay with image analysis
The migration and distribution of bacteria in each image were quantified using a 
Matlab (Mathworks, Natick, MA) image-analysis subroutine developed in house, as 
described previously (90). Briefly, the analysis consisted of the following steps: (i) 
removal of background pixels in the image based on pixel size and intensities; (ii) 
determination of the center of the image (i.e., where bacteria enter the observation 
chamber), using the dead cells (red fluorescence) as a reference; (iii) location of green 
cells (i.e., live bacteria expressing GFP) in the images relative to the center, determined 
by calculating the centroid; and (iv) quantification of the number of live cells in 16 µm-
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wide intervals. These steps were repeated for each image, and the total counts of cells in 
100 images were summed for analysis. 
The migration profile was used to calculate the chemotaxis migration coefficient 
(CMC), which weights the migration of cells by the distance they move from the center 
of the observation chamber, as previously described (95). For example, a cell that moves 
to the farthest high-concentration position at the right (interval 64) receives a weighting 
factor of +1, and a cell that moves to the farthest low-concentration position at the left 
(interval 1) is given a weighting factor of -1. Green cells in the middle of the chamber 
(intervals 31-34) were excluded from the analysis on the grounds that they could be non-
motile or poorly motile cells. The motility migration coefficient (MMC) was determined 
in the same way as the CMC except that the weighting factor was positive in both 
directions. Examples of assays used to calculate CMC and MMC values are shown in Fig. 
3.2. 
The CMC value represents the magnitude of the chemotactic response to the steep 
exponential gradients that are generated with ten-fold increases in the attractant 
concentration in each of the five inlet ports, from left to right. The cells were pre-incubated 
for ten minutes with the same concentration of attractant present in the middle (third) inlet, 
which is the concentration they experience when entering the chamber. The MMC value 
represents the extent of the smooth-swimming response of cells in chemotaxis buffer (CB) 
that are introduced into a chamber with a uniform concentration of attractant. The cells do 
not adapt to the attractant until they spread across the chamber. If they adapt before 
reaching the point along the channel at which their distribution is imaged, their movement 
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will be random run-tumble behavior that will not significantly affect the final distribution 
across the chamber. 
III.3.7 Preparation of motile bacteria for chemotaxis assays
Bacteria were prepared for chemotaxis assays as described by Mao et al. (95). 
Overnight cultures of GFP-expressing bacteria, grown overnight at 32oC in TB containing 
150 µg/mL erythromycin, were inoculated into 25 mL of the same medium lacking 
erythromycin to a turbidity of ~0.05 at 600 nm. Cultures were grown with swirling in 125 
ml Erlenmeyer flasks at 32oC to mid-exponential phase (turbidity of ~0.5 at 600 nm), with 
addition of 100 M IPTG for induction of Tsr expression from the pRR53-tsr and 
pCA24N-tsr plasmids. A 3-mL aliquot of cells was centrifuged at 400 x g for 5 min at 
room temperature and gently resuspended in 2 mL of CB. TG1 cells expressing RFP were 
killed by exposure to 1 mM kanamycin for 1 h (complete killing was verified by lack of 
growth on LB agar plates) and mixed with GFP-expressing motile cells at approximately 
equal densities. The microflow chemotaxis assay was performed within 20 min after 
resuspension of the bacteria in CB, which contained attractants at the concentration 
expected at the midpoint of the observation chamber, e.g., 500 nM in a 0-50 M 
exponential gradient. In some experiments, bacteria were prepared as described above but 
primed by addition of 2 M NE to the TB growth medium 1 hr before harvesting. Cells 
introduced into uniform concentrations of attractants were resuspended in non-
supplemented CB, except as noted. 
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0-5 M DHMA 0-50 M DHMA 0-500 M DHMA 0-5 mM DHMA 0-200 M Ser CB only 
CB only 0.5 nM DHMA 5 nM DHMA 50 nM DHMA 500 nM DHMA 5 M DHMA 
CB only 0.5 nM Ser 5 nM Ser 50 nM Ser 500 nM Ser 5 M Ser 
A
B
C
FIG. 3.2. Images of µFlow assays for non-linear gradients and uniform attractant concentrations. A) Non-linear (exponential) 
gradients over the indicated range of concentrations from left to right across the 1 mm-wide observation channel. Composite 
images were taken 14-15 mm along the 2 mm channel. Flow from bottom to top. Motile CV1 cells are labeled with GFP, and 
non-motile TG1 cells are labeled with RFP. Cells suspended in CB containing the midpoint concentration of attractant (e.g., 
50 nM for the 0-5 M gradient) were introduced in the middle of the channel. B) Cells suspended in CB were introduced into 
the middle of the channel containing the indicated uniform concentrations of DHMA. C) Cells suspended in CB were 
introduced into the middle of the channel containing the indicated uniform concentrations of serine.  
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III.3.8 RNA isolation and quantitative RT-PCR (q-RT-PCR)
Bacteria were grown using the protocol described above for the µFlow assay, with or 
without priming. After 60 min exposure to NE, cells were collected by centrifugation and 
stored at -80°C prior to RNA extraction. RNA was extracted using the Nucleospin RNA 
II kit (Clontech, CA) according to the protocol recommended by the manufacturer. Cells 
grown without NE were used as negative controls. Total RNA was isolated from the cell 
pellets, and RNA quality was spectrophotometrically assessed. qRT-PCR was performed 
using iScript one-step RT-PCR kit with SYBR green (Bio-Rad Laboratories, CA) on a 
MyiQ single-color real-time PCR detection system (Bio-Rad Laboratories). The threshold 
cycles, as calculated by the MyiQ optical system software (Bio-Rad Laboratories), were 
used to determine the relative changes between samples. The experiments were run in 
triplicate in 25 µl reactions, and 50 ng of total RNA was used for each reaction, with the 
final forward and reverse primer concentrations at 0.15 µM each. After amplification, 
template specificity was ensured through melting-curve analysis. The rrsG (ribosomal 
RNA G) transcript was used as the housekeeping RNA for normalizing the data. 
III.3.9 Determination of the number of molecules of DHMA in the periplasm
The mean volume of an E. coli cell grown in a moderately rich medium like TB has 
been estimated at around 4 femtoliters (4 x 10-15 liter) (125), and the volume of the 
periplasm has been estimated to be 20-40% of the total cell volume (126). Thus, 1 x 10-15 
liter is a reasonable estimate for the average periplasmic volume. At 5 nM (5 x 10-9 
moles/liter), a concentration of DHMA that still generates an attractant response, there are 
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thus about 5 x 10-24 moles of DHMA in the periplasm, assuming equilibration with the 
external medium. Multiplying by Avogadro’s number of 6 x 1023 molecules/mole, this 
yields about 3 molecules of DHMA in the periplasmic space of a single cell. 
III.4 Results
III.4.1 An E. coli K-12 strain shows chemotaxis towards norepinephrine
To examine NE chemotaxis, we used the K-12 strain RP437 (120), a standard for 
studies of E. coli chemotaxis. Strain RP437 is henceforth called CV1 to conform to the 
nomenclature used for the chemoreceptor-mutant strains used in this study. 
We employed a microflow device manufactured in house (90) to monitor chemotaxis 
to NE. This assay offers several advantages for studying the response to biological signals. 
First, the microliter volumes involved minimize the amount of a chemical that must be 
used per assay. Second, the migration of bacteria can be observed in stable gradients of 
almost any desired profile. These gradients are established in a mixing device and are 
oriented perpendicular to the direction of flow. Third, because the microflow chamber is 
only 1 mm wide, the gradients formed can be very steep. Finally, the time for the bulk 
flow to reach the site of imaging is ∼20 sec, so that the short-term responses of the cells 
can be recorded. 
Cells harvested from TB did not respond to NE in the microflow assay, a result in 
contrast to the earlier reports with the microplug assay (27) . However, in the microplug 
assay, cells are exposed to NE for 30 min or longer. We therefore tested whether prior 
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exposure to NE primes the cells to respond. Cells grown in TB supplemented with 2 M 
NE for 1 hr before harvesting showed a robust response to NE (Fig. 3.3) that was 
equivalent to the response observed with similar gradients of serine (Fig. 3.3; Fig. 3.2). 
The effects of pre-exposure to NE were eliminated when 12.5 g/mL chloramphenicol 
was added at the same time as NE, suggesting that protein synthesis is required for the 
effect (Fig. 3.3). Chemotaxis to serine and aspartate, sensed as attractants by the Tsr and 
Tar chemoreceptors, respectively, was unaffected by chloramphenicol. These results 
suggest that preincubation with NE induces the synthesis of proteins that are required for 
NE to be sensed as an attractant. 
III.4.2 Chemotaxis toward NE requires induction of bacterial enzymes
One pathway for NE metabolism in mammals involves deamination to form 3,4-
dihydroxyphenyl-glycol-aldehyde (DOPEGAL) followed by oxidation to form 3,4-
dihydroxymandelic acid (DHMA) (73). These steps in E. coli can potentially be carried 
out by two enzymes: a periplasmic tyramine oxidase TynA (127) and a cytoplasm 
aromatic aldehyde dehydrogenase FeaB (127). Quantitative reverse transcription 
polymerase chain reaction (qRT-PCR) analysis showed that tynA transcription increased 
4.5-fold and feaB transcription increased 3.5-fold after 1 hr of incubation with 2 M NE, 
(Fig. 3.4B). The SP101 and SP102 mutants, which lack TynA and FeaB, respectively, 
failed to respond to NE in the microflow assay (Fig. 3.5). 
The quorum-sensing kinase QseC has been implicated in NE-induced expression of 
virulence and motility genes in pathogenic E. coli and S. enterica (71, 113). Induction of 
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FIG. 3.3. Chemotaxis Migration Coefficient (CMC) values for cells in exponential 1-500 
M NE and 1-200 M serine and aspartate gradients. Error bars represent the standard 
deviation of the mean for triplicate experiments. Primed indicates that cells were grown 
in the presence of 2 M NE for 1 hr before harvesting. Abbreviations used: CB, 
chemotaxis buffer; NE, norepinephrine; Asp, aspartate; Ser, serine; Cam, 
chloramphenicol. *indicates not assayed. 
 
tynA and feaB transcription by exposure to NE was abolished in a qseC mutant SP103 
(Fig. 3.4B), which also showed a large decrease in NE chemotaxis (Fig. 3.5). These results 
suggest that NE sensed by QseC induces tynA and feaB transcription, and hence 
production of DOPEGAL and DHMA. 
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FIG. 3.4. Bacterial genes encode enzymes that can produce DHMA from NE. (A) The 
chemical pathway shown is present in the human GI tract, and E. coli potentially has a 
similar capability via TynA and FeaB, as indicated. (B) Induction of tynA and feaB 
transcription by preincubation with 2 M NE in wild-type and qseC cells. The levels of 
transcript were measured by q-RTPCR 60 min after addition of 2 M NE to the culture. 
Controls were incubated 60 min in the absence of NE. The results are normalized to the 
level of the rrsG transcript. The error bars represent the standard deviation of the mean. 
III.4.3 DHMA is a potent attractant for E. coli
DOPEGAL is not commercially available, but DHMA proved to be a very strong 
attractant for strain CV1 (Fig. 3.6). Representative images of the microflow assays with 
DHMA are shown in Fig. 3.2. The response to DHMA was strongest in an exponential 
gradient of 0-50 M. The CMC value was 0.12 in a 0-5 M gradient, 0.22 in a 0-50 M 
gradient, 0.09 in a 0-500 M gradient, and 0.06 in a 0-5000 M gradient (Fig. 3.6). The 
BA
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simplest explanation for the decreased response at higher concentrations of DHMA is that 
the receptor became saturated. Strain CV12, which contains only Tsr and Aer, gave a 
FIG. 3.5. NE chemotaxis in mutants defective in NE metabolism. CMC values in 
exponential gradients of 0-500 M NE and 0-200 M serine. Strains: CV1, wild type; 
SP101, tynA; SP102, feaB; SP103, qseC. Error bars represent the standard deviation 
of the mean for triplicate experiments. Primed indicates that cells were grown in the 
presence of 2 M NE for 1 hr before harvesting. *indicates not assayed. 
much weaker response to DHMA. This difference may be due to altered ligand sensitivity 
in strains that contain only one type of high-abundance chemoreceptor (128, 129). 
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FIG. 3.6. CMC values for cells in exponential DHMA gradients. The gradients ranged 
from 0 to the indicated value in µM. Strains: CV1, wild type; CV12, tar-tap, trg; SP101, 
tynA. Error bars represent the standard deviation of the mean for triplicate experiments. 
Primed indicates that cells were grown in the presence of 2 µM NE for 1 hr before 
harvesting. 
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III.4.4 Chemotaxis to DHMA requires the Tsr chemoreceptor and its intact serine-
binding site 
CV5 cells that lack Tsr did not respond to serine or DHMA, although their response 
to aspartate was the same as that of CV1 cells (Fig. 3.7). We then tested whether the serine-
binding site of Tsr is required for sensing DHMA. The T156K and R69E amino acid 
replacements in Tsr disrupt the majority and minority halves, respectively, of the serine-
binding site (130). Strains TAMU101 and TAMU102, which encode Tsr-R69E and Tsr-
T156K, respectively, at the chromosomal tsr locus, also failed to respond to serine or 
DHMA in the microflow assay (Fig. 3.7). This analysis suggests that the DHMA and 
serine-binding sites in Tsr overlap.  
 
III.4.5 Heterodimeric Tsr with one functional ligand-binding site mediates responses 
to DHMA 
Tsr contains two rotationally symmetric serine-binding sites that exhibit strong 
negative cooperativity (131); Fig. 3.8A). We therefore tested the possibility that binding 
of DHMA at the second site inhibits the attractant signal produced by binding at the first 
site. The Tsr-T156K and Tsr-R69E mutant subunits were produced at approximately equal 
levels in strain TAMU104 (see Materials and Methods). In this strain, the T156K protein 
is expressed from the chromosomal tsr locus, and the R69E protein is expressed from a 
plasmid-encoded tsr gene under control of an IPTG-inducible promoter. After induction 
with 100 M IPTG, this strain produces approximately the same amount of Tsr as the 
chromosomal gene. Under these conditions, half of the Tsr molecules should be  
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FIG. 3.7. DHMA chemotaxis in tsr mutant strains. CMC values in exponential gradients 
of 0-50 M DHMA and 0-200 M serine. Strains: CV1, wild type; CV5, tsr; TAMU101, 
tsr-R69E; TAMU102, tsr-T156K; TAMU104, expresses a chromosomal tsr-T156K gene 
and a plasmid-borne tsr-R69E gene at approximately the same levels. CMC values are 
also given for TAMU104 in gradients of 0-50 M and 0-5000 M DHMA for comparison 
with the CMC values in those gradients for strain CV1 shown in Fig. 3.6. Error bars 
represent the standard deviation of the mean for triplicate experiments. Primed indicates 
that cells were grown in the presence of 2 M NE for 1 hr before harvesting. *indicates 
not assayed. 
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heterodimers with one intact ligand-binding site and one doubly defective site (Fig. 3.8B). 
A similar approach has been used to show that Tar (132, 133) and Tsr (134, 135) 
heterodimers of this type still mediate attractant responses to their respective ligands. In 
contrast to CV1 cells, TAMU104 cells exposed to 100 M IPTG responded robustly to 
DHMA in gradients of 0-50 M up to 0-5000 M (Fig. 3.7). Thus, when Tsr has only one 
functional ligand-binding site, it mediates good chemotaxis responses at higher 
concentrations of DHMA. 
FIG. 3.8. Complementation of mutations that disrupt the majority and minority half-
binding sites for serine. A) The periplasmic domain of the Tsr homodimer. Squares 
indicate the majority site, triangles the minority site. The ligand is shown in blue, with the 
square end representing the -amino and -carboxyl groups of and amino acid ligand and 
the pointed end the R group. Ligands can bind with equal affinity to either one of the 
rotationally symmetric binding sites. Both sites can be occupied, but binding to the second 
typically occurs with strong negative cooperativity. B) The residue substitutions 
introduced by mutations, indicated by the red Xs, are T156K for the majority site and 
R69E for the minority site. Neither mutant homodimer is capable of binding ligand. If the 
two mutant receptors are co-expressed at equal levels, half of the Tsr dimers will be 
heterodimers (T156K/R69E) that retain one intact ligand-binding site.  
T156K R69E
T156K/R69E
B
 
 XX 
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In a second assay, cells resuspended in chemotaxis buffer (CB) in the absence of 
DHMA were introduced into the microflow chamber containing various uniform 
concentrations of DHMA in CB. In this assay, a smooth-swimming response is indicated 
by enhanced spreading of cells in both directions from the midpoint at which they enter 
the channel. This spreading is quantified in a term we call the motility migration 
coefficient (the MMC value, as described in Materials and Methods). The difference in 
the responses used to determine the CMC and MMC values is illustrated in Fig. 3.9A, and 
the full spectrum of responses to uniform concentrations of DHMA and serine is presented 
in Fig. 3.2. A more complete discussion of the behaviors quantified in the CMC and MMC 
assays is given in Materials and Methods under the heading Quantification of chemotaxis 
in the µFlow assay with image analysis. 
Wild-type CV1 cells had an MMC value of 0.16 in chemotaxis buffer (CB). In 
comparison, exclusively smooth-swimming CV16 cells, which lack all four canonical 
chemoreceptors, had an MMC value of 0.40 in CB. The increased spreading probably 
occurs with smooth-swimming cells because they rapidly reach the floor or ceiling of the 
20 m tall chamber and move laterally in the channel without being caught up in the bulk 
flow that would quickly wash them through the chamber. As shown in Fig. 3.9B, CV1 
and TAMU104 cells already showed increased MMC values at 5 nM (0.0005 M) 
DHMA, whereas TAMU101 (TsrR69E) and TAMU102 (TsrT156K) cells first showed 
increased MMC values at 500 nM (0.5 M) and 5 M DHMA, respectively. Thus, the two 
point mutations in tsr do not make the cells totally unresponsive to DHMA, but they 
decrease the response sufficiently to prevent detectably higher CMC values in exponential 
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FIG. 3.9. A) Representative images of the microflow assay illustrating both CMC and 
MMC assays. 1 is chemotaxis buffer only; 2 is a 0-50 M exponential gradient of DHMA; 
3 is a uniform concentration of 500 nM DHMA; 4 is a uniform concentration of 500 nM 
serine. B) MMC values for different tsr mutants in exponential gradients of DHMA from 
0 to the indicated concentration. Strains: CV1, wild type; CV5, tsr; TAMU101, tsr-
R69E; TAMU102, tsr-T156K; TAMU104, chromosomal tsr-T156K, plasmid-borne, 
salicylate-inducible tsr-R69E. Error bars represent the standard deviation of the mean for 
triplicate experiments. 
0-50 M DHMA CB only 500 nM DHMA 500 nM Ser 
A
B
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DHMA gradients in our microflow assay. CV1 cells introduced into the chamber after 
being exposed to DHMA for 20 min at the same concentration they encounter in the 
chamber did not show MMC values above 0.16 at any DHMA concentration, so the cells 
did adapt to the presence of DHMA, as they do to serine. CV1 cells first showed an 
increase in MMC value at 500 nM serine, indicating that Tsr senses DHMA about 100 
times more sensitively than it senses serine (Fig. 3.10). The MMC values for serine 
plateaued at 5 M and remained between 0.40 and 0.45 up to 5 mM. The MMC values 
plateaued at 0.5 to 0.55 with 0.5 and 5 M DHMA but then dropped significantly at 500 
M. The MMC values at 500 M and 5 mM DHMA were the same as the buffer control. 
In contrast, TAMU104 cells expressing heterodimeric Tsr with only one ligand-binding 
site responded with increased MMC values at concentrations up to 5 mM, although they 
reached their plateau value of 0.40 to 0.5 at the same 0.5 M concentration as CV1 cells. 
This result is consistent with the idea that DHMA interacts with the second Tsr ligand-
binding site to cancel out the attractant signal evoked by binding at the first site. We saw 
no obvious increase in tumbling at high concentrations of DHMA, which should be 
reflected in lower MMC values. Therefore, binding to the second site does not generate 
an obvious repellent response. Binding at the second site must occur with lower affinity, 
as is expected because of the negative cooperativity that exists between the two sites (131, 
136). 
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FIG 3.10. MMC values for different tsr mutants in exponential gradient from 0 to the 
indicated concentration of DHMA or serine. Strains: CV1, wild type; TAMU104, 
chromosomal tsr-T156K, plasmid-borne, salicylate-inducible tsr-R69E. The DHMA data 
for CV1 are an extension of those shown in Fig. 3.9B. Error bars represent the standard 
deviation of the mean for triplicate experiments. 
III.5 Discussion
This study made the following discoveries. 1) The RP437 K-12 strain of E. coli 
exhibits chemotaxis to norepinephrine (NE). This highly motile, non-pathogenic strain 
possesses all of the chemoreceptors found in enterohemorhagic E. coli (EHEC) (137) and 
shares the high-abundance chemoreceptors Tar and Tsr with S. enterica. 2) Chemotaxis to 
NE requires induction of the periplasmic tyramine oxidase, TynA, and the aromatic 
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aldehyde dehydrogenase, FeaB, through a signaling pathway that requires the quorum-
sensing histidine protein kinase QseC. Thus, the observed chemotactic response to NE is 
indirect. 3) 3,4-dihydroxymandelic acid (DHMA), a metabolite of NE that could be made 
by the combined activities of TynA and FeaB, is a potent chemoattractant for E. coli K-
12 with effective concentrations ≤ 5 nM, suggesting that chemotaxis to NE is actually 
chemotaxis to DHMA. 4) DHMA is sensed by the serine chemoreceptor Tsr. 5) Mutant 
variants of Tsr defective in the majority (Tsr-T156K) or minority (Tsr-R69E) halves of 
the cross-dimer serine-binding site are defective in DHMA chemotaxis. 6) A 
heterodimeric receptor consisting of one subunit of Tsr-T156K and one subunit of Tsr-
R69E, which has only one functional serine-binding site, mediates good chemotaxis to 
DHMA. 7) Cells expressing wild-type Tsr show a decreased response to DHMA at 
concentrations above 50 M, whereas cells expressing the Tsr-156K/Tsr-R69E 
heterodimer do not show a decreased chemotaxis response at high concentrations of 
DHMA. Although these results make the basic mechanism of chemotaxis to NE and 
DHMA clear, they leave several questions unanswered. 
III.5.1 How can cells respond to such low concentrations of DHMA?
Assuming equilibration between the concentration of unbound small molecules in the 
environment and the periplasm, at an external DHMA concentration of 5 nM there should 
be about 3 molecules of free periplasmic DHMA (see Material and Methods). Diffusion 
of small molecules trapped within the periplasmic space is very rapid, so that localization 
of the chemoreceptors at a sub-polar patches (138) should not be limiting for the kinetics 
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of detection of DHMA. If Tsr binds DHMA very tightly, the number of Tsr receptors 
occupied by DHMA at 5 nM DHMA may be considerably higher than 3. In any case, the 
response to DHMA is exquisitely sensitive. 
The binding of one additional attractant molecule per second is adequate to cause a 
measurable increase in counterclockwise flagellar bias (139, 140). Rates of change in 
bound DHMA should certainly occur in cells moving laterally in the steep gradients 
present in the observation chamber of our microflow device. The sensitivity of the 
response is enhanced by the high amplification seen within the receptor patch (the activity 
of ∼35 CheA kinases inhibited per molecule of attractant bound) (129) and by the high 
positive cooperativity (Hill coefficient of ~11) in adjusting the rotational bias of the 
flagellar motor to changes in intracellular CheY-phosphate (141). 
III.5.2 The microflow assay is ideal for studying chemotaxis to biological signals
The observation chamber in the microflow assay is only 20 m high. Thus, chemotaxis 
in the microflow assay is essentially a two-dimensional excursion. This geometry may 
provide a good simulation of the spatial context in which chemotaxis occurs in the 
intestine. The physiologically relevant response to NE or its metabolites in the intestine 
could be largely a surface phenomenon that occurs when the cells swim within or under 
the mucosal layer, which is only a few hundred m thick and lies in close proximity to the 
intestinal epithelium. The gradients in the microflow assay can be made very steep, a 
condition that may also reflect the situation in vivo. With conventional assays for 
chemotaxis, it is unlikely that we could have observed a response that peaks at 5-50 M 
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DHMA and then disappears at higher concentrations. We anticipate that the microflow 
assay will be suitable for screening bacterial chemotaxis to a wide range of biological 
signaling molecules in a spatial and temporal context similar to that in which chemotaxis 
probably occurs in the host intestine. 
III.5.3 Why do cells respond only to low concentrations of DHMA?
Unlike the typical situation in which responses plateau at high concentrations of 
attractant, the smooth-swimming response to DHMA disappears at higher concentrations 
(Fig. 3.10). This effect is not seen if the second of the two ligand-binding sites of the Tsr 
homodimer is eliminated, as in the R69E/T156K heterodimer (Fig. 3.8B). One possible 
explanation is that DHMA binds to the second site with negative cooperativity (131, 136), 
and, by so doing, cancels out the attractant signal generated by binding to the first site. 
The mechanism for this phenomenon remains to be elucidated, but in vivo it would be 
expected to cause cells to congregate in regions with intermediate concentrations of 
DHMA. 
III.5.4 Is NE/DHMA chemotaxis an important factor in gut/microbe interactions?
The DHMA that bacteria encounter in the GI tract could be generated by the host or 
by bacterial metabolism. The ability of NE to induce the synthesis of bacterial enzymes 
that convert NE to DHMA suggests that resident bacteria play an important role in 
generating localized DHMA gradients. Because FeaB and the other aldehyde 
dehydrogenases are presumably confined to the cytoplasm, to respond to NE the 
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DOPEGAL generated by periplasmic TynA would have to be taken up by the cells and 
converted to DHMA, which would then be released back into the periplasm. A similar 
mechanism is observed for E. coli chemotaxis to lactose (142). Lactose must be taken up 
into the cell by lactose permease (143) and split into glucose and galactose by -
galactosidase (144). One or both of these monosaccharides must then reenter the periplasm 
and bind to the MglB binding protein (145), which then has to interact with the Trg 
chemoreceptor (146). However, in the intestine, motile cells probably respond to DHMA 
gradients generated by bacteria that have already colonized the intestinal epithelium. Thus, 
sensitivity to low concentrations of DHMA is consistent with the idea that chemotaxis to 
DHMA has biological significance. 
Endogenous DHMA production is normally low in sympathetic neuronal tissues (73), 
but it may be produced from NE by bacteria that have already colonized NE-rich areas on 
the intestinal epithelium. Among such sites would be the Peyer’s patches near the junction 
of the jejunum and ileum, which are favored locations for colonization and invasion by 
enteric bacteria (147). By navigating to loci of NE leakage, cells could encounter the 
higher concentrations of NE that are required for induction of virulence genes (71). 
Furthermore, stress increases release of NE by the sympathetic innervation of the gut and 
heightens the severity of bacterial infection in the GI tract (116), and high levels of NE 
enhance growth of E. coli in serum-based media in vitro (68). This effect is also seen as a 
temporary and reversible increase in fecal coliforms in the mouse intestine in the presence 
of pharmacologically induced high levels of NE in the mouse (62). The combination of 
induction of virulence genes by NE and chemotaxis to its metabolite DHMA may work 
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together to heighten the pathogenicity of enteric bacteria that possess a Tsr-like 
chemoreceptor.  
It is intriguing that the serine receptor Tsr, typically reported to be the most abundant 
of the E. coli chemoreceptors (148), also senses two biological signaling molecules, the 
intradomain quorum-sensing compound AI-2 (97) and the interdomain signaling molecule 
DHMA. It is exciting to contemplate that microfluidic assays may uncover other secrets 
about old friends in the chemotaxis signaling pathways of bacteria. 
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Table 3.1. List of strains and plasmids 
Strain or plasmid Relevant genotype or other characteristics 
Antibiotic 
resistancea 
Source 
E. coli strains 
CV1 
Wild type for chemotaxis; equivalent to RP437 thr(Am)-1 
leuB6 his-4 metF(Am)159 rpsL136 [thi-1 ara-14 lacY1 
mtl-1 xyl-5 eda tonA31 tsx-78]  
Str (120) 
CV5 CV1 tsr thr+ 
Str (97) 
CV12 CV1 (tar-tap) trg::Tn10 eda+ 
Str;Tet (97) 
CV16 CV1 tsr thr+ (tar-tap) trg::Tn10 eda+ 
Str;Tet (97) 
BW25113tynA BW25113tynAΩKan 
Kan (121) 
BW25113feaB BW25113feaBΩKan 
Kan (121) 
BW25113qseC BW25113qseCΩKan 
Kan (121) 
SP101 CV1 tynA Str; Kan This study 
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Table 3.1. Continued 
Strain or plasmid Relevant genotype or other characteristics 
Antibiotic 
resistance 
Source 
SP102 CV1 feaB 
Str; Kan This study 
SP103 CV1 qseC Str; Kan This study 
UU2641 RP437 serB::kan-ccdB 
Str; Kan Parkinson (personal 
communication) 
UU2375 
RP437 tsr-R69E (tar-tap)∆5201 (aer)∆1 ygjG::Gm 
(trg)∆4543 
Str Parkinson (personal 
communication) 
UU2376 
RP437 tsr-R69E (tar-tap)∆5201 (aer)∆1 ygjG::Gm 
(trg)∆4543 
Str Parkinson (personal 
communication) 
TAMU100 CV1 serB::kan-ccdB This study 
TAMU101 CV1 tsr-r69E This study 
TAMU102 CV1 tsr-T156K This study 
TAMU104 TAMU101/pRR53-tsrR69E 
This study 
TG1 
supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5, (rK-mK-); F' 
[traD36 proAB+ lacIq lacZΔM15] 
Stratagene 
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Table 3.1. Continued 
Strain or plasmid Relevant genotype or other characteristics 
Antibiotic 
resistance 
Source 
Plasmids    
pCM18 GFP expression vector 
Erm (149) 
pDS-Red Express RFP expression vector 
Amp Clontech 
pRR53-tsrR69E Expresses Tsr-R69E under control of IPTG 
Amp (135) 
a
 Abbreviations for antibiotics: Str, streptomycin; Tet, tetracycline; Kan, kanomycin; Erm, erythromycin; Cm, chloramphenicol; 
Amp, ampicillin 
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CHAPTER IV 
CONVERSION OF NOREPINEPHRINE TO 3,4-DIHDROXYMANDELIC ACID 
IN ESCHERICHIA COLI REQUIRES THE QSEBC QUORUM-SENSING 
SYSTEM AND THE FEAR TRANSCRIPTION FACTOR* 
IV.1 Overview
The detection of norepinephrine (NE) as a chemoattractant by E. coli K-12 requires 
the combined action of the TynA monoamine oxidase and the FeaB aromatic aldehyde 
dehydrogenase. These role is to convert NE into 3,4-dihydroxymandelic acid (DHMA), 
which is a potent chemoattractant sensed by the Tsr chemoreceptor. These two enzymes 
must be induced by prior exposure to NE, and cells that exposed to NE for the first time 
initially show minimal chemotaxis toward it. The induction of TynA and FeaB requires 
the QseC quorum-sensing histidine kinase, and the signaling cascade requires new protein 
synthesis. Here, we demonstrate that the cognate response regulator for QseC, the 
transcription factor QseB, is also required for induction. The related quorum-sensing 
kinase QseE appears not to be part of the signaling pathway, but its cognate response 
regulator, QseF, which is also a substrate for phosphotransfer from QseC, plays a non-
essential role. 
*Reprinted in part with permission from “Conversion of Norepinephrine to 3,4-
Dihdroxymandelic Acid in Escherichia coli Requires the QseBC Quorum-Sensing System 
and the FeaR Transcription Factor” by Sasi Pasupuleti, Nitesh Sule, Michael D. Manson, 
Arul Jayaraman, 2017, Journal of Bacteriology, In Press. Copyright by American 
Society for Microbiology. 
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The promoter of the feaR gene, which encodes a transcription factor that has been shown 
to be essential for the expression of tynA and feaB, has two predicted QseB-binding sites. 
One of these sites appears to be in an appropriate position to stimulate transcription from 
the P1 promoter of the feaR gene. This study unites two well-known pathways: one for 
expression of genes regulated by catecholamines (QseBC) and one for expression of genes 
required for metabolism of aromatic amines (FeaR, TynA and FeaB). This cross talk 
allows E. coli to convert the host-derived and chemotactically inert NE into the potent 
bacterial chemoattractant DHMA. 
IV.2 Introduction
Catecholamine hormones and neurotransmitters, an overlapping set of host-derived 
molecules, profoundly affect the resident microbiota of the mammalian gut (66, 69, 116). 
It is apparent that these molecules are also important in regulating the virulence of 
invading pathogens (16, 27, 150, 151). In particular, the QseBC and QseEF two-
component systems of enteric bacteria have been shown to mediate these responses to 
catecholamines (71, 113, 152-156). 
We recently demonstrated (157) that some of the effects reported for norepinephrine 
(NE) and other catecholamines in enterohemorrhagic E. coli (EHEC) (158) can also be 
evoked by a non-amine metabolite of NE, 3,4-dihydroxymandelic acid (DHMA). In 
addition to inducing virulence gene expression in EHEC, DHMA is a chemoattractant for 
both EHEC (157) and a non-pathogenic K-12 strain of E. coli, RP437 (159). The 
chemotaxis response to DHMA is mediated by the Tsr chemoreceptor, which is present in 
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both EHEC and non-pathogenic K-12 strains of E. coli. Tsr homologs are present in a 
number of other enteric bacteria, as well, including Salmonella enterica (160, 161), 
Enterobacter aerogenes (162) , and Pseudomonas aeruginosa (163). 
DHMA is made in two enzymatic steps from NE. The first step is carried out by a 
primary amine oxidase, TynA, which produces the intermediate 3,4-dihydroxyphenyl-
glycol-aldehyde (DOPEGAL), and the second step is catalyzed by an aromatic aldehyde 
dehydrogenase, FeaB (127). TynA and FeaB are also produced by other enteric bacteria, 
where their characterized function is the utilization of aromatic amines as nitrogen sources 
and, in at least one case, as a carbon source (164). The expression of TynA and FeaB in 
E. coli RP437 requires prior exposure to NE and subsequent protein synthesis, and the 
induction of tynA and feaB transcription depends upon the presence of the histidine protein 
kinase QseC (159). 
FeaR is a transcriptional regulator of the AraC family (164) and has been characterized 
as an essential transcription factor for the expression of tynA and feaB in response to 
exposure to aromatic amines. The feaR, feaB and tynA genes are adjacent but are 
divergently transcribed (164). The feaB and tynA genes have separate promoters and are 
somewhat differently regulated, although both promoters have two well-defined, tandem 
FeaR-binding sites upstream of the -35 region of their respective promoters (164). 
In this study, we investigated the QseC-dependent signaling pathway by which NE is 
converted to DHMA. We found that the QseC signaling pathway requires its cognate 
response regulator QseB and, to a lesser extent, the related response regulator QseF. One 
output of this pathway is the expression of FeaR. We conclude that cross talk between the 
64 
regulatory systems for virulence and metabolism of aromatic amines may depend upon 
the ability of QseBC and, to a lesser extent, QseF to regulate feaR as well as genes directly 
involved in virulence. 
IV.3 Materials and methods
IV.3.1 Bacterial strains, growth conditions and materials.
E. coli RP437 ((120); noted here as CV1) was used as the wild-type E. coli strain. 
GFP-expressing CV1 cells were obtained by transforming with plasmid pCM18 (149) and 
used to visualize migration to NE in the microfluidic chemotaxis assay. The pCM18 
plasmid was maintained in cultures using 100 g/mL erythromycin. CV1 qseB, qseE, 
qseF, or feaR kan-insertion mutations were generated as described previously (159). 
Briefly, mutations were introduced into strain CV1 by phage P1vir transduction using 
lysates generated from the respective mutants in the Keio collection (121). Mutants were 
selected for kanamycin resistance on lysogeny broth containing 1.2% Difco Bacto agar 
and 50 g/mL kanamycin. All gene disruptions were confirmed by PCR. 
Liquid cultures were grown in tryptone broth (TB; 10 g/L tryptone and 8 g/L NaCl) 
containing the appropriate antibiotics. Norepinephrine (>99% purity) was obtained from 
Spectrum Chemicals (Gardena, CA). 
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IV.3.2 Microfluidic chemotaxis assay
Motile bacteria were prepared for chemotaxis assays as described by Mao et al (95). 
Cultures of GFP-expressing bacteria were grown in TB containing 100 μg/ml 
erythromycin. Overnight cultures were inoculated into the same medium to a turbidity at 
600 nm of ~0.05. The cultures were grown with swirling in Erlenmeyer flasks at 30°C. At 
a turbidity of ~0.35, 8 µM NE or solvent blank was added to the cultures and further 
incubated to mid-exponential phase (turbidity at 600 nm of ~0.5) before harvesting for 
experiments. Mid-exponential phase cells were centrifuged at 400g for 10 min at room 
temperature and gently resuspended in chemotaxis buffer (CB; physiological buffered 
saline with 10 mM potassium phosphate, pH 7.0, containing 0.1 mM EDTA, 0.01 mM L-
methionine, and 10 mM DL-lactate). 
All microflow chemotaxis experiments were performed within 20 min after 
resuspension of the bacteria in CB. The assay was performed as described previously 
(159). A mixture of GFP-expressing, motile test cells and red fluorescent protein (RFP)-
containing, dead TG1 cells was gently resuspended in CB. 500 μl gas-tight glass syringes 
(Hamilton, Reno, NV), containing either CB or CB with chemoeffector, were carefully 
connected to the inlets of the gradient generator module to avoid introducing air bubbles 
into the device. The bacterial suspension was introduced into the chemotaxis chamber, 
using a 50 μl gas-tight glass syringe. The flow rate in the microfluidic device was 
maintained at 2.1 µl/min, using a Fusion 400 programmable pump (Chemyx Inc., Stafford, 
TX). The assembled device was positioned on the stage of a TCS SP5 confocal resonant-
scanner microscope (Leica Microsystems Inc., Buffalo Grove, IL). For each assay, 100 
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images for each fluorophore were collected 7 mm from the inlet at 2.5 sec intervals. The 
2.5-sec imaging interval was chosen based on our calculation that free-floating bacteria 
moving at a flow rate of 2.1 μl/min take an average of 2.5 s to traverse 1,000 μm, the 
imaging field of view (94). The bacteria in the middle of the flow were exposed to the 
gradient for an average of 18 to 21 s prior to imaging. Cells spending more time in contact 
with the floor or ceiling of the chamber move more slowly (94). 
 
IV.3.3 Quantification of chemotaxis in the microflow assay with image analysis 
The migration and distribution of bacteria in each image were quantified using an in-
house developed program. Briefly, the analysis consisted of the following steps: (i) 
removal of background pixels in the image, based on pixel size and intensities; (ii) 
determination of the center of the flow chamber (i.e., where bacteria enter the observation 
chamber), using dead cells (red fluorescence) as a reference; (iii) location of green cells 
(i.e., live bacteria expressing GFP) in the images relative to the center, by determining the 
centroid; and (iv) calculation of the motility migration coefficient (MMC) based on the 
location of the migrated motile cells. These steps were repeated for each image, and the 
total counts of cells in 100 images were summed for analysis to generate migration 
profiles. The MMC is calculated by weighting the migration of cells by the distance they 
move in either direction from the center of the observation chamber, as previously 
described (159). The MMC value represents the extent of the smooth-swimming response 
of cells in CB that are introduced into a chamber with a uniform concentration of 
attractant. The cells do not adapt to the attractant until they spread across the chamber. If 
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they adapt before reaching the point along the channel at which their distribution is 
imaged, their movement will be random run-and-tumble behavior that will not 
significantly affect the final distribution across the chamber. 
 
IV.3.4 RNA isolation and qRT-PCR 
Bacteria were grown in TB as described above, and the mutant strains were grown in 
the presence of 50 µg/ml kanamycin. At mid-exponential phase (after 60 min of exposure 
to NE), cell pellets were collected by centrifugation and stored in RNAprotect® (Qiagen, 
CA) at -80°C prior to RNA extraction. Total RNA was isolated from the cell pellet using 
RNeasy Mini kit (Qiagen, CA) with the protocol provided by the manufacturer. RNA 
purity was assessed using the ratio of absorbance at 260 and 280 nm. All samples had 
A260/A280 ratio of > 2.0. qRT-PCR was performed on a LightCycler® 96 (Roche, IN) using 
iScript™ One-Step RT-PCR kit with SYBR green (Bio-Rad Laboratories, CA) and gene-
specific primers, using the protocol recommended by the manufacturer The reaction 
volume was 25 L, with 50 ng of RNA per reaction and 0.15 M of each primer. The 
threshold cycle numbers (Ct), were obtained using the Light Cycler system software 
(Roche, CA). Fold-changes in expression with NE exposure relative to untreated cells 
were calculated using the ΔΔCt method (165), and the rrsG (rRNA G) transcript was used 
as the housekeeping gene for data normalization. All qRT-PCR experiments were repeated 
with three different cultures and two technical replicates per culture.  
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IV.4 Results and discussion 
 
IV.4.1 The QseC signaling pathway induces TynA and FeaB expression 
To study the signaling pathway that induces the enzymes that convert norepinephrine 
(NE) into the chemoattractant DHMA, we first studied the chemotaxis responses of mutant 
strains of E. coli lacking the relevant sensor kinases (qseC or qseE) and the corresponding 
response regulators (qseB or qseF), using the quantitative Motility Migration Coefficient 
(MMC) assay (159). All strains responded normally to the control attractant, 10 M L-
serine (Fig. 4.1). The wild-type strain, CV1, and the CV1ΔqseE mutant responded 
strongly, and essentially identically, to NE in the MMC assay, suggesting that qseE is not 
involved in the conversion of NE to DHMA (Fig. 1). On the other hand, the ΔqseC mutant 
did not respond to NE as an attractant in the MMC assay (Fig. 1), which confirms that 
QseC plays an essential role. The CV1qseB mutant also did not respond to NE, whereas 
the CV1qseF mutant gave a somewhat attenuated chemotaxis response. These results 
demonstrate that the QseBC histidine kinase/response regulator system is required for 
induction of TynA and FeaB.  
Although the histidine kinase QseE does not seem to play an important role, QseF, 
the cognate response regulator activated by QseE, does seem to be involved. This 
observation is consistent with that of Moreira and Sperandio (153), who showed that QseF 
can also be a substrate for phosphorylation by QseC in Salmonella. The MMC values for 
the CV1, CV1qseE and CV1qseF strains were all highest when the NE concentration 
was 50 M and were lower at both 5 and 500 M.  
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FIG. 4.1. Chemotaxis of E. coli RP437 and mutants to NE. Cells were exposed to 0, 5, 
50, or 500 µM NE in the microfluidic device, as described in Materials and Methods. 
Serine (10 µM) was used as the positive control. The Motility Migration Coefficients 
(MMCs) are shown. Data presented are the means and standard deviations from 3 
independent experiments carried out in duplicate. * and ** indicate statistical significance 
for the mutant compared to WT at the given NE concentration, using the Student t-test at 
a significance level of p<0.05 and 0.005 respectively. # indicates statistical significance 
for serine compared to the buffer control (no NE) in each strain, using the Student t-test at 
a significance level of p<0.0001. 
 
It should be noted that the dose-response curve for NE is shifted to higher 
concentrations by two orders of magnitude compared to that of DHMA (159). This seems 
to be a reasonable effect, given that NE must be converted to DOPEGAL by TynA in the 
periplasm, be taken into the cell as DOPEGAL, be converted to DHMA by FeaB, and then 
exported back to the periplasm to interact with the periplasmic sensory domain of Tsr. We 
see the same general pattern for the dose response to a step increase in concentration for 
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both DHMA and NE, as measured in the MMC assay, although shifted to a 100-fold higher 
concentration with NE. 
 
IV.4.2 Role of FeaR in the signaling pathway 
The FeaR transcription factor is required for the expression of the tynA and feaB genes 
(164, 166). The feaR, tynA and feaB genes are clustered in the E. coli chromosome, with 
feaR being transcribed divergently from the other two. We therefore tested the ability of 
the CV1ΔfeaR mutant to respond to NE. These cells responded normally to 10 M L-
serine but failed to respond to NE at any concentration tested (Fig. 4.2). Thus, FeaR is 
required for E. coli to produce a chemotaxis response to NE, presumably through its role 
in transcription of the tynA and feaB genes. 
We then determined whether expression of feaR increases in cells exposed to NE. 
Figure 4.3 shows that feaR transcription, as measured by qRT-PCR, increased by 2.7 fold 
more when CV1 cells were incubated for 60 min with 8 µM NE than when the cells were 
incubated for 60 min in the absence of NE. No difference in the increase in feaR 
transcription over time, with or without NE incubation, was observed with the CV1ΔqseC 
and CV1ΔqseB strains, a result that is consistent with their lack of response in the MMC 
assay. The increase in the induction of feaR transcription in the CV1ΔqseE mutant after 
60 min exposure to NE relative to incubation of this strain for 60 min without NE was 
similar to that seen with CV1 (2.8 fold), indicating that QseE plays little or no role in the 
signaling pathway. On the other hand, the increase in the transcription of feaR in the 
CV1ΔqseF mutant after 60 min exposure to NE was 1.6-fold higher than the increase after  
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FIG. 4.2. Chemotaxis of E. coli RP437 ΔfeaR to NE. Cells were exposed to 0, 5, 50, and 
500 µM NE in the microfluidic device as described in Materials and Methods. Serine (10 
µM) was used as the positive control. The Motility Migration Coefficients (MMCs) are 
shown. Data shown are the means and standard deviations from 3 independent 
experiments carried out in duplicate. * indicates statistical significance for serine 
compared to the buffer control (no NE), using the Student t-test at a significance level of 
p<0.0001. 
 
60 min of incubation without NE. This modest decrease in feaR expression suggests that 
QseF plays some role in the induction of feaR transcription. Even in the absence of QseE, 
phosphorylation of QseF by QseC apparently produces enough QseF-P for full induction 
of feaR transcription. 
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FIG. 4.3. Induction of feaR transcription in wild-type E. coli RP437 and the Δqse mutants. 
The expression of feaR was quantified by qRT-PCR before and after incubation for 60 
min in cells treated with 8 µM NE. Cells that were incubated with 0 mM NE for 60 min 
were used as the negative control. The fold-increase in feaR mRNA after incubation is 
shown. Data shown are the means and standard deviations from three independent 
experiments carried out in duplicate. * and ** indicate statistical significance for NE 
treatment compared to control, using the Student t-test at a significance level of p < 0.005 
and 0.05, respectively. 
 
IV.4.3 Induction of TynA and FeaB 
Because NE increased the transcription of feaR, which in turn is known to regulate 
tynA and feaB, we next investigated how the transcription of tynA and feaB changes upon 
incubation with NE in the wild-type and mutant strains. Figures 4.4 show that the 
transcription of both tynA and feaB increased by 2.4-fold more in CV1 cells incubated  
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FIG. 4.4. Induction of tynA and feaB transcription in wild-type E. coli RP437 and Δqse 
mutants. The expression of tynA and feaB was quantified by qRT-PCR before and after 
incubation for 60 min in cells treated with 8 µM NE. Cells that were incubated without 
NE for 60 min were used as the negative control. The fold-increase in tynA and feaB 
mRNA after incubation is shown. Data shown are the means and standard deviations from 
three independent experiments carried out in duplicate. * indicates statistical significance 
for NE treatment compared to control, using the Student t-test at a significance level of p 
< 0.005. 
 
for 60 min with NE relative to cells incubated for 60 min in the absence of NE. Consistent 
with the data in Figure 4.3, the increase in transcription of tynA and feaB in the CV1ΔqseE 
mutant (2.5 and 2.9-fold more after 60 min incubation with NE compared to 60 min of 
incubation without NE, respectively) was similar to the wild type. No difference in the 
increase in tynA or feaB transcription with or without NE was seen in the CV1ΔqseC, 
CV1ΔqseB or CV1ΔfeaR mutants. The CV1ΔqseF strain again fell into an intermediate 
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category, with NE boosting transcription of tynA and feaB 1.8 and 1.6 fold, respectively, 
after incubation with NE compared to incubation without NE. 
 
IV.4.4 Sequence analysis of the feaR promoter 
An examination of the regulatory region of the fearR, tynA and feaB genes suggests a 
mechanism that could explain our results. Both the MMC chemotaxis assay and the 
analysis of the induction of feaR, feaB and tynA transcription by pretreatment with NE 
show that QseC and QseB are essential for production of FeaB and TynA by an indirect 
mechanism involving the FeaR transcription factor. The data also suggest that the response 
regulator QseF, which can be phosphorylated by both its cognate histidine kinase QseE 
and by cross talk from QseC, is required for maximal induction by NE.  
Inspection of the feaR regulatory region shows that it contains three promoters (164) 
and two predicted binding sites for QseB (Fig. 4.5, shown in cyan) (167) in the feaR 
regulatory region, based on the consensus binding site of QseB determined for qseBC and 
flhDC. One of the QseB-binding sites, which matches the CAATTACGAATTA 
consensus sequence (167) at 9/13 positions and at all four of the highly conserved A bases 
(in bold and underlined), overlaps the Pm transcription start site and is 11 base pairs 
upstream of the -35 region of the P1 promoter. The other, which matches the consensus at 
7/13 positions and at all four of the highly conserved A residues, overlaps the P2 
transcription start site. Although we do not know which of the three feaR promoters is 
responsible for the induction of feaR transcription, the position of the putative QseB- 
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FIG. 4.5. Analysis of the feaR promoter. The feaR promoter sequence and the predicted 
QseB binding sites (32; highlighted in cyan) are shown. The last four and three bases 
(GACA and ACA) of the 3' ends of the possible QseF binding sites (33) are highlighted 
in yellow; the two-base overlap between the promoter-distal putative QseF and QseB-
binding sites are highlighted in purple. Proposed promoter elements (−35 and −10) 
associated with the three mapped transcription start sites (164), shown by horizontal 
rightward-pointing arrows, are underlined. 
 
binding sites suggests that the P1 promoter is the most likely candidate. Also, the P1 
promoter has the closest match to the 70 -35 and -10 consensus sequences.  
It is possible that the activity of P2, and perhaps even transcription initiated at P1, 
would be inhibited by the binding of QseB to its downstream binding site. If the affinity 
of QseB-P for the upstream site is higher than the affinity for the downstream site, feaR 
transcription could be maximally induced at intermediate levels of QseB-P and repressed 
at higher levels of QseB-P. 
The consensus binding site for QseF has been determined for only one gene, glmY, 
which encodes a small non-coding regulatory RNA (168). There is no obvious match to 
the 18-base QseF consensus sequence in the FeaR regulatory region, although the GACA 
bases that overlap the -10 region of Pm and the ACA bases that overlap the -35 region of 
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P2 (highlighted in yellow in Fig. 4.5) are the last four and three bases, respectively, of the 
reported QseF consensus binding site. Although we can make no definitive statement 
about whether QseF interacts with the feaR regulatory region, the short sequence 
homologies we observe are perhaps in the right position for QseF to bind in conjunction 
with QseB. 
 
IV.5 Conclusion 
Based on our results, we propose a model to explain how NE induces its own 
metabolism to DHMA (Fig. 4.6). In this model, NE binds to QseC to activate its kinase 
activity. QseC then phosphorylates its cognate response regulator, QseB, and to a lesser 
extent, its non-cognate response regulator, QseF. The phosphorylated response regulators 
induce transcription of the feaR gene, perhaps by binding upstream of the P1 feaR 
promoter. The FeaR protein, in turn, activates the transcription of the feaB and tynA genes, 
whose products convert NE to DHMA. Note that, because of the convoluted way in which 
NE serves as an attractant, high levels of both TynA and FeaB may be needed to produce 
enough DHMA to be sensed as an attractant by Tsr.  
The paradigm we have just outlined suggests that the extraordinarily thorough work 
of Julius Adler in the 1960s and 1970s (169) may have missed some important 
chemoeffectors for E. coli, including biological signaling molecules in addition to 
nutrients For example, we found that the quorum-sensing signal autoinducer-2 is an 
attractant for E. coli that is sensed by binding to the periplasmic LsrB protein, which then  
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FIG.4.6. Proposed model for conversion of NE to DHMA. NE binds to QseC, which leads 
to phosphorylation of QseB and, to a lesser extent, QseF. QseF will also be phosphorylated 
by QseE (not shown) if QseE is present. Phosphorylated QseB, with help from QseF, 
induces transcription of the feaR gene. The FeaR dimer induces the transcription of the 
feaB and tynA genes (open arrows) by binding upstream of their respective promoters. 
Note that QseB-P and QseF promote transcription of many other genes than feaR (152, 
155, 156) and that feaR is regulated by numerous other transcription factors than QseB 
and QseF (164). The TynA protein is exported to the periplasm, where it acts as a 
monoamine oxidase to convert NE to DOPEGAL (DG). DG is taken into the cytoplasm 
by an uncharacterized transporter, where the aromatic aldehyde dehydrogenase FeaB 
oxidizes it to DHMA (DH). DH is delivered to the periplasm by an uncharacterized 
exporter, where it binds to the Tsr chemoreceptor to evoke an attractant chemotaxis 
response. 
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interacts with Tsr (97). The realization that a host molecule like NE must be metabolized 
to DHMA for it to be sensed as an attractant suggests that other important chemoeffectors 
may be produced only by metabolism. Thus, screens for chemoeffectors should be 
performed after growing cells in the presence of candidate molecules, a procedure that is 
routinely followed for organisms like Pseudomonas putida that can utilize an enormous 
catalog of possible organic compounds (170). Such processes for generating 
chemoeffectors might be important for the pathogenesis of enteric pathogens such as 
EHEC, as we have observed for NE and DHMA (157). Host-derived compounds like NE 
and DHMA might also play important roles in interactions among the many organisms of 
the microbiome. 
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CHAPTER V 
MODELING OF CHEMOTAXIS BEHAVIOR OF BACTERIA IN 
MICROFLUIDIC DEVICES USING PROBABILISTIC APPROCH 
 
V.1 Overview 
Mathematical models of bacterial chemotaxis can be used to obtain insights on the 
effect of various factors on the chemotaxis behavior of bacteria in aqueous solutions. If 
these models are predictive in nature, they can also be used to minimize the experimental 
space and the number of experiments needed to comprehensively investigate the 
chemotaxis response of bacteria to a chemoeffector. While several mathematical models 
have been developed to describe different aspects of bacterial chemotaxis (100-109), many 
of them focus on chemotactic processes at cellular level by considering the mechanistic 
interactions between the intracellular signaling cascades, and do not predict the bacterial 
migration in a given environment. Accurate description of bacterial migration is essential 
to account for the effects of spatial and temporal variations on the observed chemotaxis 
response in flow systems, particularly in microfluidic device.  
In this study, we present a probabilistic model to predict the chemotaxis behavior of 
the bacteria in a stable exponential gradient of chemoeffector in microfluidic devices. 
Time dependent bacterial distribution profiles were simulated for a 500 × 50 × 10 µm 
microfluidic device using MATLAB®. The simulations suggest that the time dependent 
bacterial migration in the microfluidic device is influenced by bulk motion of the fluid and 
existing concentration gradient of chemoeffector.  
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V.2 Introduction 
The results presented in Chapters III and IV clearly demonstrate the utility of the 
µFlow assay for investigating the chemotaxis response to molecules such as NE and 
DHMA. As described earlier (98), a chemoeffector is mixed with buffer in a laminar flow-
based diffusive mixing chamber and is introduced into the observation chamber of the 
device. In the device, a parabolic velocity profile and a stable concentration gradient is 
maintained. The chemotaxis response is quantified by determining the distribution of 
bacteria along the width of the chemotaxis chamber near the exit (Fig.3.1). The 
chemotaxis response of the bacteria in the microfluidic device depends on three factors –
shape (or steepness) of the concentration gradient, velocity of the fluid stream carrying the 
chemoeffector, and the maximum concentration used to generate gradient of the 
chemoeffector molecule. The effect of these three variables is discussed below. 
The shape of the concentration gradient plays a significant role in the observed 
chemotaxis response. Hegde et al (97) have shown that E. coli RP437 does not migrate 
towards serine when the concentration gradient (0 – 200 µM) is linear across the width of 
the chemotaxis chamber. However, when the serine spatial concentration gradient strength 
is steep (i.e., a non-linear gradient), E. coli RP437 demonstrates strong chemotaxis 
migration towards serine, indicating that the shape of concentration gradient can impact 
the observed chemotaxis response. Similarly, Englert et al. (90) showed that the velocity 
of the fluid also affects the extent of spreading across the chemotaxis chamber (98) and 
hence, and chemotaxis migration coefficient (CMC). It was observed that the CMC value 
for E. coli RP437 in 0 – 225 µM NiSO4 gradient  decreased from -0.18 to -0.14 when the 
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flow rate reduced from 1500 nl/min to 1000 nl/min. The experimental results provided in 
chapter III (Fig.3.6) support the fact that maximum concentration used to generate 
gradient of the chemoeffector molecule also affects the extent of chemotaxis response in 
microfluidic device. It was noticed that the CMC value for E. coli RP437 increased from 
0.12 to 0.21 when the concentration gradient of DHMA was changed from 0 – 5 µM to 0 
– 50 µM.  
More importantly, the factors that impact chemotaxis are not independent but are 
coupled. For example, a strong chemotaxis response towards DHMA was observed when 
E.coli RP437 was presented a 0-50 µM non-linear gradient at a flow rate of 2100 nL/min. 
Changing the concentration gradient or its shape or flow rate results in attenuation of the 
observed chemotaxis response. As a result, optimization of these coupled variables 
requires carrying out numerous time and resource intensive experiments.  
Pioneering work on mathematical modeling of bacterial chemotaxis has been carried 
out by Keller and Segal (108), and this model forms the basis for all subsequent 
mathematical models describing bacterial chemotaxis (171). Originally developed to 
model the movement of slime molds Keller-Segal model is widely used to describe the 
changes in density of bacterial population as function of attractant gradient in a given 
system. However, this model do not account for the active motion of the bacteria and 
single cell dynamics. In addition, it is always challenging to obtain numerical solutions to 
Keller-Segal model without several assumptions.  Therefore, it is important to develop a 
mathematical model, which can be used to identify a small set of optimal conditions to be 
tested for a specific chemoeffector molecule and minimize the number of experiments 
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required. In this work, we propose a simple and efficient modeling framework based on 
probability distribution functions to model the bacterial chemotaxis in microfluidic device.  
 
V.3 Model development 
We initially considered a 2D plane along the length of the chemotaxis chamber of 
dimensions L × W × H (Fig.5.1). The domain is divided in to small units called ‘cells’ and 
the total number of cells in the entire domain are m×n. The location of each cell can be 
represented as (xi,yi), and bacteria are allowed to move from one cell to another cell 
(Fig.5.2). For example, if a bacterium initially at (xi,yi) moves to (xi
*,yi
*) in time Δt then 
the probability associated with this event can computed as  
 
 
 
 
 
 
 
FIG. 5.1. Chemotaxis chamber 
 
        (5.1) 𝑝(𝑥, 𝑦) =  
exp ൬−
(𝑥𝑖 − 𝑥𝑖
∗)2 + (𝑦𝑖 − 𝑦𝑖
∗)2
2𝐷ο𝑡 ൰
ξ2𝜋𝐷ο𝑡
 
 
 
 
flow 
L 
W 
H 
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Theoretically, bacteria from any one cell may move to other (m×n)-1 cells or may 
remain in the cell. Therefore, there will be m×n events associated with movement of 
bacteria from one cell, and corresponding probabilities associated with each event. Since, 
there are m×n cells and each cell is associated with m×n probabilities, we define the 
probability matrix of the entire domain as the transition matrix ‘T’ which is given by:   
                           
 
 
FIG.5.2. 2D domain of chemotaxis chamber 
 
We now define position matrix, X, whose elements represent the probability of finding 
the bacteria in any give cell at time‘t’. For a given position matrix at time ‘t’, X (m×n) × 1 , 
the transformed position matrix after time ‘Δt’ can be calculated as 
 
 
T =  [p(x, y)](m×n) × (m×n)         (5.2) 
𝑋 (𝑡 + Δ𝑡) = 𝑇 ∗ 𝑋 (𝑡)         (5.3) 
yi 
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V.3.1 Incorporation of velocity 
It is observed that in the absence of flow the bacteria migrate randomly in all 
directions, but in the presence of flow bacteria migrate primarily in the direction of flow 
due to the bulk motion of fluid. To account for this effect, velocity is incorporated in to 
the eqn.5.1. It is assumed that the flow is laminar and fully developed. 
 
 
 
 
V.3.2 Incorporation of concentration gradient 
It is known that bacterial movement is influenced by the presence of chemical gradient. 
Based on the direction of migration with respect to the chemical gradient the response is 
called either attraction or repulsion. To account for this effect concentration term is 
incorporated in to the eqn.5.4. It is assumed that the gradient is exponential. 
 
 
        (5.4) 
𝑝(𝑥, 𝑦) =  
exp ൬−
(𝑥𝑖 − 𝑥𝑖
∗)2 + (𝑦𝑖 − 𝑦𝑖
∗ − 𝑣ο𝑡)2
2𝐷ο𝑡 ൰
ξ2𝜋𝐷ο𝑡
 
𝑣 =  𝑣𝑚𝑎𝑥 ൬
𝑥𝑖
𝑊
−  
𝑥𝑖
𝑊
 
2
൰          (5.5) where 
 𝑝(𝑥, 𝑦) =  
exp ൬−
(𝑥𝑖 − 𝑥𝑖
∗ ± 𝐶)2 + (𝑦𝑖 − 𝑦𝑖
∗ − 𝑣ο𝑡)2
2𝐷ο𝑡 ൰
ξ2𝜋𝐷ο𝑡
            (5.6) 
𝐶 = 𝐶 ′𝑒𝑥𝑝 (
𝑎𝑥𝑖
𝑤
)          (5.7) where 
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V.3.3 Extending the model to 3D 
Eqn. 6 can be used to determine the probability associated with the event in which the 
bacteria moves from (xi,yi) to (xi
*,yi
*) in 2D space containing velocity and concentration 
gradients. By incorporating the ‘z’ co-ordinate eqn. 5.6 can be written as  
 
 
Eqn. 5.8 can be used to determine the probability associated with the event of bacterial 
movement from (xi,yi,zi) to (xi
*,yi
*,zi
*) in 3D space containing velocity and concentration 
gradient. 
 
V.4 MATLAB® simulations 
Theoretical validation of the proposed model was carried out by computing the 
transition matrix ‘T’ for a chemotaxis chamber with dimensions 500 × 50 × 10 µm. For a 
given position matrix, X(t), the transformed position matrix X(t+Δt) was computed as per 
eqn. 5.3. The cells were introduced near the entrance (length =0, width =25, height =5) 
and the distribution of probability in 3D was shown in the Figures 5.3, 5.4 5.5, and 5.6. 
The simulation results are categorized into the following cases: (1) no flow and no 
concentration gradient, (2) flow with no concentration gradient (3) flow with 
concentration gradient (attraction), and (4) flow with concentration gradient (repulsion). 
Figures 5.3 and 5.4 depict the effect of fluid flow on the temporal bacterial distribution in 
   𝑝(𝑥,𝑦, 𝑧) =  
exp ൬−
(𝑥𝑖 − 𝑥𝑖
∗ ± 𝐶)2 + (𝑦𝑖 − 𝑦𝑖
∗ − 𝑣ο𝑡)2 + (𝑧𝑖 − 𝑧𝑖
∗)2
2𝐷ο𝑡 ൰
ξ2𝜋𝐷ο𝑡
 
     (5.8) 
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the chemotaxis chamber. As it can be seen from the simulations for the case of no flow 
and no concentration gradient, the bacteria are distributed around the entrance point after 
2 s (Fig. 5.3A) and remained at the entrance (with more spread) even 10 s (Fig. 5.3B) after 
their introduction into the chamber, whereas appreciable migration  of bacteria can be seen 
in the case of flow with no concentration gradient (Fig.5.4). In this case, bacteria has 
reached approximately middle of the chamber in 2 s (Fig. 5.4A and the end of the chamber 
in 5 s (Fig. 5.4A) after their introduction. Case 3 and 4 are simulated by assuming an 
exponential concentration gradient and by changing the sign of C’ in the equation 8. For a 
positive C’ attraction response is observed (Fig. 5.5) similarly for negative C’ repulsion 
response is observed (Fig. 5.6). Although, the bacterial distribution appear to be similar 
for the case of 3 and 4 around at 2 s (Fig. 5.5A, Fig. 5.6A), the bacteria migrated towards 
the higher concentration (Fig. 5.5B), and towards the lower concentration (Fig. 5.5B) 
within 5 s of their introduction in the chemotaxis chamber.  
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FIG. 5.3. Temporal probability distribution of bacteria in 3D space for the case of no flow 
and no concentration gradient. Migration of bacteria in the chemotaxis chamber of 500 × 
50 × 10 µm size after (A) 2 s and (B) 10 s of their introduction. 
 
A B 
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FIG. 5.4. Temporal probability distribution of bacteria in 3D space for the case of flow 
and no concentration gradient. Migration of bacteria in the chemotaxis chamber of 500 × 
50 × 10 µm size after (A) 2 s and (B) 5 s of their introduction.  
A B 
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FIG. 5.5. Temporal probability distribution of bacteria in 3D space for the case of flow 
and concentration gradient (attractant). Migration of bacteria in the chemotaxis chamber 
of 500 × 50 × 10 µm size after (A) 2 s and (B) 5 s of their introduction. 
 
A B 
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 FIG. 5.6. Temporal probability distribution of bacteria in 3D space for the case of flow 
and concentration gradient (repellent). Migration of bacteria in the chemotaxis chamber 
of 500 × 50 × 10 µm size after (A) 2 s and (B) 5 s of their introduction. 
 
A B 
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V.5 Discussion 
The probabilistic model presented in this Chapter  provides a simple yet efficient way 
to model bacterial migration in the µFlow device. For theoretical validation of the model 
we used a random bacterial motility coefficient (D) of 1×10-7 cm2/s and chemotactic 
sensitivity coefficient (𝐶′) of 2×10-7 cm2/s. These values are an order of magnitude lower 
than the values reported previously for other wild-type strains of E. coli in a bulk aqueous 
environment. The explanation for using such low values of D and 𝐶′ is that the dimension 
of our chemotaxis chamber used in simulations are 10-fold smaller in length and width 
compared to the chemotaxis chamber of microfluidic device used in the experiments. In 
addition, we used a velocity of 100 µm/s for the fluid flow which is also an order of 
magnitude smaller than the velocity in the microfluidic device. Therefore, using low 
values of D and 𝐶′ is particularly important to visually notice the temporal changes in the 
bacterial distribution within the chemotaxis chamber. 
While our results show good agreement between simulations and experimental data 
for a smaller dimension, it was not possible to extend the simulations to the actual 
microfluidic device dimensions because of the associated computational cost. The 
transition matrix that is generated in these simulations is extremely expensive in terms of 
computational memory. For example, to compute the Transition Matrix (T) for three 
dimensional space of 500 × 50 × 10 µm requires ~2 TB of computational memory of 
supercomputer. If we use syntax T=zeros(m,n) to initialize the matrix. Later, we found 
that utilizing the sparse allocation method of matrix initialization (T=spalloc(m,n,nnz(T))) 
greatly reduces the memory required, however, the problem with this type of syntax is 
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very long execution time. Table 5.1 provides comparative information between the new 
and old syntax operations. From the Table 5.1 it is clear that the new syntax is more 
memory efficient but takes more time to compute. Therefore, more efficient programming 
code needs to be developed to minimize the computational time and memory.  
 
Table 5.1. Comparison between old and new syntax in terms of computational memory 
and time. 
  
Size 
 (L ×W×H) 
Size of ‘T’ Matrix Computational time 
Old Syntax New Syntax Old Syntax New Syntax 
10 ×10×10 8 MB 1 MB 0.5 s 25 s 
20 ×10×10 32 MB 2 MB 1 s 200 s 
20 ×20×10 120 MB 4 MB 5 s 25 min 
40 ×20×10 480 MB 8 MB 20 s 200 min 
40 ×40×10 1.8 GB 16 MB 80 s 25 h 
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CHAPTER VI 
SUMMARY AND FUTURE DIRECTIONS 
 
VI.1 Summary 
 We investigated the chemotaxis response of E. coli RP437 towards NE using a 
microfluidic device (Chapter III) and determined that the response to NE requires priming 
the cells during growth with a lower concentration of NE. We further determined that a 
non-linear concentration gradient of NE was required for detecting a significant 
chemotaxis response to NE. In addition, we identified that priming with NE during growth 
was required for NE chemotaxis and  de novo expression of two enzymes TynA and FeaB 
was required for chemotaxis. Together, this led to the novel finding that NE was converted 
to DHMA by TynA and FeaB enzymatic activity, and DHMA was the actual 
chemoattractant for E. coli RP437.  
We further demonstrated that chemotaxis to DHMA requires the Tsr chemoreceptor 
and the minimum concentration required for a detectable chemotaxis response through Tsr 
was ~5 nM. We also observed significant reduction in the chemotaxis response at DHMA 
concentrations greater than 50 µM and determined that negative cooperativity between the 
two serine binding sites resulted in attenuation of chemotaxis at concentrations greater 
than 50 µM.   
 We also investigated the mechanism underlying the conversion of NE to DHMA 
(Chapter IV) in E. coli RP437. We identified that the conversion of NE into DHMA 
requires the QseC histidine kinase and its cognate response regulator QseB, and to a lesser 
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extent, the response regulator QseF. Our data also suggest that the feaR transcription factor 
is a downstream target for QseB and is required for tynA and feaB expression. This work 
is significant as it suggest that host-derived signals such as NE can be converted by 
commensal bacteria to a potent chemoattractant, which can then recruit pathogens that 
possess Tsr-like receptors to the site of infection.  
 We also developed a probabilistic model to simulate the chemotaxis behavior of 
bacteria in microfluidic devices (Chapter V). The time-dependent distribution of bacteria 
in the chemotaxis chamber was simulated using MATLAB®. We determined that the time 
dependent bacterial migration in the micro-flow device is influenced by bulk motion of 
the fluid and existing concentration gradient of chemoeffector. The probabilistic model 
can be used to reduce the experimental space required to test the response of an unknown 
chemoeffector in the microfluidic device.  
 
VI.2 Future directions 
 Identification of the NE metabolite DHMA as a chemoattractant for E. coli leads to 
the hypothesis that metabolites from other aromatic neurotransmitters and hormones can 
also be chemoattractants. Specifically, dopamine, tyramine and serotonin are all aromatic 
compounds with primary amines that are present in the GI tract.  A survey of the data in 
the Kyoto Encyclopedia of Genes and Genomes (KEGG) REACTION database indicates 
that these molecules are potential substrates for primary amine oxidases like TynA or other 
monoamine oxidases. The expected products from these neurotransmitters upon 
deamination and oxidation (the reactions carried out by TynA and FeaB, respectively) are 
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3,4-dihydroxyphenylacetate (DHPA), 4-hydroxyphenylacetate (HPA) and 5-
hydroxyindoleactetate (HIA) (Table 6.1). Therefore, these metabolites can be tested to 
determine if they generate a chemotaxis response. Furthermore, it is also possible that 
DHMA is not the final product in NE metabolism and DHMA can be further metabolized 
into other compounds such as vanillylmandelic acid (VMA, also known as 4-hydroxy 3-
methoxymandelic acid). Therefore, another line of investigation could be to determine if 
metabolites derived from DHMA are also chemoattractants for E. coli RP437. Lastly, it is 
of interest to determine the structure-function relationship between DHMA and Tsr that 
leads to chemotaxis. Specifically, the role of the 3’- and 4’-hydroxyl groups in interacting 
with the DHMA binding site in Tsr needs to be investigated further. 
Since DHMA induces virulence and pathogenesis in EHEC O157:H7 (157), one 
hypothesis emerging out of this work is that DHPA, HPA, and HIA also promote virulence 
in pathogenic bacteria. The effect of these metabolites to induce the expression of the locus 
of enterocyte effacement (LEE) genes in EHEC O157:H7 can be tested using qRT-PCR. 
In addition, the effect of metabolites on EHEC O157:H7 attachment to cultured intestinal 
epithelial cells in vitro can also be investigated.  
Our results show that QseB or QseF are required for feaR expression. However, we 
have not yet determined if these transcription factors directly bind to the feaR promoter or 
whether their effects are mediated through a different transcription factor. Interactions 
between QseB and feaR promoter DNA can be tested using Electrophoretic Mobility Shift 
Assay (EMSA).  QseB/QseF protein can be purified under native conditions as described 
previously (172) by overexpression in a CV1ΔqseB/pqseB+ or CV1ΔqseF/pqseF+ strain. 
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Table 6.1 Metabolite candidates for identifying those that are both virulence factors and 
chemoattractants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The purified QseB/QseF protein should be mostly unphosphorylated while its sensor 
kinase, QseC or QseE, will be expressed at normal, wild-type levels. The feaR promoter 
region can be amplified using polymerase chain reaction (PCR) and end-labelled with [γ-
32P]-dATP. Mobility shift assays using feaR promoter fragments and purified QseB/QseF 
can be carried out using standard protocols for protein-DNA interactions (173). If QseB 
or QseF directly bind to the feaR promoter region, we expect the protein-DNA complex 
to migrate slower than the DNA or the free protein.  
Host enteric 
neurotransmitters 
Metabolic products from primary 
amine oxidase and aldehyde 
dehydrogenase reactions 
NE 
Dopamine 
Tyramine 
Serotonin 
DHMA 
DHPA 
HPA 
HIA 
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The probabilistic model that was developed in chapter V can be validated by 
comparing model simulations with actual experimental data from the response to 
canonical chemoattractants such as serine and aspartate. After obtaining the fitted 
parameters of the model, D and 𝐶′, simulations can be run with different flow rates and 
concentration gradients and shape of gradients to obtain optimal response space for a new 
ligand that binds directly to Tsr or Tar. Finally, the model can be extended to capture the 
response of bacteria to ligands with different binding affinity towards the receptor by 
incorporating another parameter (Kd) into the model. A cheRB mutant strain can be used 
to obtain the experimental data to fit the model parameter Kd. 
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